Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/image5_1.png
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/image3_1.jpeg
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/.DS_Store
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/image7_1.jpeg
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/image2_1.png
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/image4_2.png
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/image6_1.png
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/image4_1.png
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/renamed
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/images.txt
Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury-images/image8_1.jpeg
Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity-images/image3_1.png
Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity-images/image3_2.png
Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity-images/image3_3.png
Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity-images/image3_5.png
Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity-images/image3_6.jpeg
Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity-images/image3_4.jpeg
Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity-images/image2_1.jpeg
Expression of bovine (Bos indicus) interleukin-18 in Escherichia coli and its biological activity-images/images.txt
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/image4_2.jpeg
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/image1_1.jpeg
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/image9_1.jpeg
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/image10_2.jpeg
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/image9_2.jpeg
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/image10_1.jpeg
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/images.txt
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/image4_1.jpeg
Association and Evidence for Linked Recognition of Type IV Secretion System Proteins VirB9-1, VirB9-2 and VirB10 in Anaplasma marginale-images/image8_1.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image4_2.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image1_1.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image7_1.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image5_1.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image7_3.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image2_1.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/images.txt
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image7_2.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image6_1.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image4_1.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image8_1.jpeg
Upregulation of cytochrome P450 2J3-11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway-images/image1_2.jpeg
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image3_1.png
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image5_1.png
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image5_2.png
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image7_1.jpeg
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image2_1.png
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image4_2.png
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image4_3.png
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image6_1.png
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/image4_1.png
Cloning and Expression of the 44-Kilodalton Major Outer Membrane Protein Gene of the Human Granulocytic Ehrlichiosis Agent and Application of the Recombinant Protein to Serodiagnosis-images/images.txt
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/image11_1.jpeg
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/image5_1.png
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/image3_1.jpeg
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/image7_1.jpeg
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/image6_1.png
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/image4_1.png
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/image10_1.jpeg
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/images.txt
Katanin Localization Requires Triplet Microtubules in Chlamydomonas reinhardtii-images/image8_1.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_13.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image1_2.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_2.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image1_1.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_3.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_9.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_4.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image6_6.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image6_5.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image7_1.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_8.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image6_4.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_18.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_14.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image6_1.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image6_3.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image5_1.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image6_2.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image9_1.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image6_7.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_6.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_1.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image9_2.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_17.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_15.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_16.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_7.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_5.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_12.png
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/images.txt
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_11.jpeg
Autoantibodies from SjÃÂgren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253-images/image8_10.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_12.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_18.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_20.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_22.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_28.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_6.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_21.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_16.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_2.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image1_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_14.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_7.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_24.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_6.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_25.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_5.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_15.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_3.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_17.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_7.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_20.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_29.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_23.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_16.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_21.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_4.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_19.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_13.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_7.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_10.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_4.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_18.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_7.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_12.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_6.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_22.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_8.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_28.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_14.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_26.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_11.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_10.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_27.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_15.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_23.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_7.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image5_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_13.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_6.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_19.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_11.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_20.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_3.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_17.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_10.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_5.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_6.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_12.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_2.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_26.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_8.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_13.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_24.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_16.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_9.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_10.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_24.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_11.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_8.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_17.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_25.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_12.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_25.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_9.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_3.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_27.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_13.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_4.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_11.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image12_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/images.txt
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_5.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_21.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_2.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_9.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_20.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_15.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_22.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_10.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_18.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_8.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_26.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_5.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_9.png
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_2.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_19.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_16.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_3.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_14.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_4.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_5.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_22.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_15.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image4_1.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image11_2.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_17.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_18.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_3.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_27.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_4.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_9.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_19.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image9_11.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_23.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image14_14.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image3_21.jpeg
Rab1A Is an mTORC1 Activator and a Colorectal Oncogene-images/image7_8.jpeg
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/image3_1.png
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/image4_2.jpeg
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/image4_3.png
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/image5_1.jpeg
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/image5_2.jpeg
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/images.txt
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/image3_2.jpeg
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/image4_1.jpeg
Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK-ERK1-2 and PI3K-Akt signaling pathways-images/image3_3.jpeg
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image8_2.jpeg
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image10_1.png
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image12_2.jpeg
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image7_1.jpeg
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image13_1.png
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image11_1.png
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image9_1.jpeg
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image8_1.png
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image12_1.jpeg
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/images.txt
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image13_2.jpeg
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer-images/image6_1.jpeg
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/image1_2.png
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/image4_2.jpeg
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/image1_1.png
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/image5_2.png
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/image6_1.png
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/image5_1.jpeg
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/image6_2.png
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/images.txt
Time-dependent onset of Interferon-a2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers-images/image4_1.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image4_2.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image1_1.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image3_1.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image4_3.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image4_4.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image3_4.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/images.txt
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image3_2.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image4_1.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image1_2.jpeg
Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: Differential expression patterns in pulmonary artery and microvascular endothelial cells-images/image3_3.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image4_2.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image1_1.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image3_1.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image4_3.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image4_4.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image2_2.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image2_3.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image5_1.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image4_5.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image2_1.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/images.txt
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image3_2.jpeg
14-3-3__ is required to prevent mitotic catastrophe after DNA damage-images/image4_1.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_10.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_4.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_11.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_13.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image4_2.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_6.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image6_3.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_7.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_3.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image3_1.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image6_2.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_2.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_1.png
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image6_5.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image6_4.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image5_1.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image5_2.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_12.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image2_1.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/images.txt
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_9.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_5.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image6_1.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image4_1.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image8_1.jpeg
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation-images/image7_8.png
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/image1_1.jpeg
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/image10_1.jpeg
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/image12_1.jpeg
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/image2_1.jpeg
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/images.txt
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/image6_1.jpeg
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/image14_1.jpeg
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/image4_1.jpeg
CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis-images/image8_1.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image1_1.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image6_3.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image6_2.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image7_1.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image5_1.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image5_2.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/images.txt
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image6_1.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image4_1.jpeg
The distribution of interleukin-19 in healthy and neoplastic tissue-images/image1_2.jpeg
Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3-images/image3_1.png
Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3-images/image7_1.jpeg
Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3-images/image9_1.jpeg
Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3-images/image10_1.jpeg
Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3-images/images.txt
Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3-images/image6_1.jpeg
Genome-wide incorporation dynamics reveal distinct categories of turnover for the histone variant H3.3-images/image4_1.jpeg
Introduction of 65 kDa Antigen of Mycobacterium tuberculosis to Cancer Cells Enhances Anti-Tumor Effect of BCG Therapy-images/image3_1.png
Introduction of 65 kDa Antigen of Mycobacterium tuberculosis to Cancer Cells Enhances Anti-Tumor Effect of BCG Therapy-images/image5_1.png
Introduction of 65 kDa Antigen of Mycobacterium tuberculosis to Cancer Cells Enhances Anti-Tumor Effect of BCG Therapy-images/image4_2.png
Introduction of 65 kDa Antigen of Mycobacterium tuberculosis to Cancer Cells Enhances Anti-Tumor Effect of BCG Therapy-images/images.txt
Introduction of 65 kDa Antigen of Mycobacterium tuberculosis to Cancer Cells Enhances Anti-Tumor Effect of BCG Therapy-images/image3_2.jpeg
Introduction of 65 kDa Antigen of Mycobacterium tuberculosis to Cancer Cells Enhances Anti-Tumor Effect of BCG Therapy-images/image4_1.jpeg
Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)-images/image6_2.jpeg
Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)-images/image7_1.png
Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)-images/image5_1.jpeg
Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)-images/images.txt
Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)-images/image7_2.jpeg
Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)-images/image6_1.jpeg
Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)-images/image4_1.jpeg
PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease-images/image3_1.png
PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease-images/image5_1.png
PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease-images/image5_2.png
PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease-images/image6_1.png
PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease-images/images.txt
PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease-images/image4_1.jpeg
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway-images/image3_1.png
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway-images/image1_1.jpeg
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway-images/image7_1.jpeg
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway-images/image4_1.png
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway-images/image5_1.jpeg
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway-images/image8_1.png
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway-images/images.txt
Dose-Dependent Effect of Estrogen Suppresses the Osteo-Adipogenic Transdifferentiation of Osteoblasts via Canonical Wnt Signaling Pathway-images/image6_1.jpeg
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image1_1.jpeg
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image5_1.png
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image3_1.jpeg
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image7_1.jpeg
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image6_2.png
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image5_2.jpeg
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/images.txt
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image6_1.jpeg
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image4_1.jpeg
Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice-images/image1_2.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image1_1.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image3_1.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image10_4.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image10_3.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image5_1.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image10_2.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image10_1.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/images.txt
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image3_2.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image6_1.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image4_1.jpeg
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K-AKT-NFkB pathway in lung cancer cells-images/image1_2.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image4_2.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image1_1.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image7_1.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image5_1.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image9_1.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image10_1.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/images.txt
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image6_1.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image4_1.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image8_1.jpeg
MKP-1 regulates cytokine mRNA stability through selectively modulation subcellular translocation of AUF1-images/image1_2.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_8.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image1_1.png
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_15.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_14.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_9.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_2.png
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image7_1.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_3.png
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_4.png
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_5.png
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_7.png
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_12.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_1.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/images.txt
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_10.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_6.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_13.png
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_16.jpeg
Identification of the pollen self-incompatibility determinant in Papaver rhoeas-images/image2_11.png
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/image3_1.jpeg
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/image7_1.jpeg
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/image9_1.jpeg
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/image10_1.jpeg
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/image12_1.jpeg
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/images.txt
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/image6_1.jpeg
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/image4_1.jpeg
TspanC8 tetraspanins regulate ADAM10-Kuzbanian trafficking and promote Notch activation in flies and mammals-images/image8_1.jpeg
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image1_3.png
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image1_1.jpeg
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image3_1.jpeg
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image1_4.png
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image7_1.jpeg
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image5_1.jpeg
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/images.txt
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image3_2.jpeg
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image6_1.jpeg
High cellular organization of pyoverdine biosynthesis in Pseudomonas aeruginosa: clustering of PvdA at the old cell poleemi_274-images/image1_2.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image4_2.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image1_1.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image3_1.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image6_2.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image7_1.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image5_1.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image7_3.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/images.txt
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image7_2.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image6_1.jpeg
Fine Specificity of Plasmodium vivax Duffy Binding Protein Binding Engagement of the Duffy Antigen on Human Erythrocytes-images/image4_1.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_2.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_10.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image8_2.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image3_2.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image3_1.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image3_6.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_11.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image8_3.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_3.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_9.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image3_4.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image3_5.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_4.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image8_4.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_2.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_3.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_8.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_20.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_4.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_21.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_18.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_9.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_5.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_7.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image3_7.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image8_5.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_5.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_6.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_17.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_14.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_6.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_16.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_8.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image3_8.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_15.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_19.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_12.png
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_7.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_1.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/images.txt
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image2_10.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_1.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image8_1.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image4_13.jpeg
Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells-images/image3_3.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image4_2.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image1_1.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image3_1.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image4_3.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image3_4.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/images.txt
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image3_2.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image1_3.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image4_1.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image1_2.jpeg
Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes-images/image3_3.jpeg
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image14_2.jpeg
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image1_1.png
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image3_1.jpeg
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image5_1.jpeg
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image9_1.jpeg
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image10_1.jpeg
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/images.txt
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image6_1.jpeg
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image14_1.jpeg
Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii-Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing Enterocolitis__-images/image8_1.jpeg
HtrA1 in human urothelial bladder cancer: A secreted protein and a potential novel biomarker-images/image9_1.jpeg
HtrA1 in human urothelial bladder cancer: A secreted protein and a potential novel biomarker-images/image10_1.jpeg
HtrA1 in human urothelial bladder cancer: A secreted protein and a potential novel biomarker-images/images.txt
HtrA1 in human urothelial bladder cancer: A secreted protein and a potential novel biomarker-images/image6_1.jpeg
HtrA1 in human urothelial bladder cancer: A secreted protein and a potential novel biomarker-images/image8_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image1_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image11_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image7_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image5_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image9_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image9_2.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image10_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/images.txt
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image6_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image4_1.jpeg
Two Functional Type VI Secretion Systems in Avian Pathogenic Escherichia coli Are Involved in Different Pathogenic Pathways-images/image8_1.jpeg
Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS-VirR Two-Component Regulatory System-images/image3_1.jpeg
Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS-VirR Two-Component Regulatory System-images/image7_1.jpeg
Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS-VirR Two-Component Regulatory System-images/image5_1.jpeg
Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS-VirR Two-Component Regulatory System-images/image5_2.jpeg
Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS-VirR Two-Component Regulatory System-images/images.txt
Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS-VirR Two-Component Regulatory System-images/image6_1.jpeg
Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS-VirR Two-Component Regulatory System-images/image4_1.jpeg
Epsilon-Toxin Production by Clostridium perfringens Type D Strain CN3718 Is Dependent upon the agr Operon but Not the VirS-VirR Two-Component Regulatory System-images/image8_1.jpeg
Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens-images/image1_1.jpeg
Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens-images/image5_1.jpeg
Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens-images/images.txt
Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens-images/image6_1.jpeg
Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens-images/image4_1.jpeg
Evaluation of Salmonella enterica Type III Secretion System Effector Proteins as Carriers for Heterologous Vaccine Antigens-images/image8_1.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image1_1.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image3_1.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image6_2.png
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image9_1.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image9_2.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image10_1.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image9_3.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/images.txt
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image6_1.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image4_1.jpeg
Frequent methylation and oncogenic role of microRNA-34b-c in small-cell lung cancer-images/image1_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_12.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_12.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_8.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_6.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_10.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_14.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_4.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_1.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image6_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_5.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_15.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_3.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_3.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_9.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_13.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_13.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_4.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_18.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_4.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_12.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_6.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image7_1.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_8.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_14.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_8.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_15.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_9.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_9.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_7.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_3.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image5_1.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_13.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_19.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_5.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_5.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_1.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_20.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_4.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image5_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_10.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_6.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_6.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_8.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_16.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_17.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_9.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_3.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_7.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_7.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_11.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image5_3.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_1.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/images.txt
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_5.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image7_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_21.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_10.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_10.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_8.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_2.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image6_1.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_6.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image5_4.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_4.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_5.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image4_1.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image8_1.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_7.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image3_3.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_9.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image12_11.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_11.jpeg
Terminalia catappa Exerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-_B and AP-1 Activity-images/image9_7.png
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_14.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_18.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_1.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image5_6.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_19.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_15.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_7.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image7_1.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_12.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_13.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image5_1.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_6.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image9_1.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image5_2.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_5.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image9_2.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_9.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_10.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_11.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_8.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_4.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image5_3.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/images.txt
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image7_2.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_16.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_20.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image5_4.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_3.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_2.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image5_5.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_21.jpeg
Renal Overexpression of Atrial Natriuretic Peptide and Hypoxia Inducible Factor-1__ as Adaptive Response to a High Salt Diet-images/image11_17.jpeg
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image3_1.png
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image7_2.png
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image5_2.png
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image7_1.jpeg
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image6_1.png
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image6_3.png
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image5_1.jpeg
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image6_2.png
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image8_1.png
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image8_2.png
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/images.txt
Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer-images/image3_2.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image1_1.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image11_1.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image6_2.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image5_1.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image9_1.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image10_1.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/images.txt
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image6_1.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image8_1.jpeg
Poison Domains Block Transit of Translocated Substrates via the Legionella pneumophila Icm-Dot System-images/image11_2.jpeg
Distinct expression of C4.4A in colorectal cancer detected by different antibodies-images/image4_2.jpeg
Distinct expression of C4.4A in colorectal cancer detected by different antibodies-images/image3_2.png
Distinct expression of C4.4A in colorectal cancer detected by different antibodies-images/image3_1.jpeg
Distinct expression of C4.4A in colorectal cancer detected by different antibodies-images/image4_3.jpeg
Distinct expression of C4.4A in colorectal cancer detected by different antibodies-images/image2_1.png
Distinct expression of C4.4A in colorectal cancer detected by different antibodies-images/images.txt
Distinct expression of C4.4A in colorectal cancer detected by different antibodies-images/image4_1.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_14.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_18.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image8_2.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_1.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image8_3.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_19.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_15.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image8_4.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_7.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_12.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_13.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image5_1.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image8_5.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_6.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image8_6.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_5.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_9.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_10.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_11.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_8.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_4.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/images.txt
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_16.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image6_1.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_20.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_3.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image8_1.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_2.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_21.jpeg
Electroacupuncture Treatment Improves Neurological Function Associated with Regulation of Tight Junction Proteins in Rats with Cerebral Ischemia Reperfusion Injury-images/image11_17.jpeg
Preparation of Monoclonal Antibodies Cross-Reactive with Orthopoxviruses and Their Application for Direct Immunofluorescence Test-images/image5_1.jpeg
Preparation of Monoclonal Antibodies Cross-Reactive with Orthopoxviruses and Their Application for Direct Immunofluorescence Test-images/images.txt
Preparation of Monoclonal Antibodies Cross-Reactive with Orthopoxviruses and Their Application for Direct Immunofluorescence Test-images/image4_1.jpeg
Association of Presence of Aspergillus Antibodies with Hemoptysis in Patients with Old Tuberculosis or Bronchiectasis but No Radiologically Visible Mycetoma-images/images.txt
Association of Presence of Aspergillus Antibodies with Hemoptysis in Patients with Old Tuberculosis or Bronchiectasis but No Radiologically Visible Mycetoma-images/image4_1.jpeg
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image1_1.jpeg
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image14_1.png
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image5_1.png
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image12_1.png
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image7_1.png
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image2_1.png
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image13_1.png
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image11_1.png
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image4_1.png
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image10_1.jpeg
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/images.txt
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image6_1.jpeg
Formation of a Polarised Primitive Endoderm Layer in Embryoid Bodies Requires Fgfr- Erk Signalling-images/image9_1.png
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image1_3.png
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image1_2.png
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image7_4.png
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image1_1.png
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image6_2.jpeg
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image7_2.png
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image7_1.png
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image5_1.jpeg
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image7_3.jpeg
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/images.txt
Investigation of the roles of T6SS genes in motility, biofilm formation and extracellular protease Asp production in Vibrio alginolyticus with modified Gateway-compatible plasmids-images/image6_1.jpeg
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image1_3.png
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image1_1.jpeg
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image3_1.jpeg
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image1_4.png
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image5_1.jpeg
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/images.txt
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image3_2.jpeg
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image6_1.jpeg
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image4_1.jpeg
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image8_1.jpeg
Interplay of RsbM and RsbK controls the sB activity of Bacillus cereuse-images/image1_2.jpeg
Molecular Cloning, Expression and Serological Evaluation of an 8-Kilodalton Subunit of Antigen B from Echinococcus multilocularis-images/image3_1.png
Molecular Cloning, Expression and Serological Evaluation of an 8-Kilodalton Subunit of Antigen B from Echinococcus multilocularis-images/image3_2.png
Molecular Cloning, Expression and Serological Evaluation of an 8-Kilodalton Subunit of Antigen B from Echinococcus multilocularis-images/image5_1.png
Molecular Cloning, Expression and Serological Evaluation of an 8-Kilodalton Subunit of Antigen B from Echinococcus multilocularis-images/image5_2.jpeg
Molecular Cloning, Expression and Serological Evaluation of an 8-Kilodalton Subunit of Antigen B from Echinococcus multilocularis-images/images.txt
Molecular Cloning, Expression and Serological Evaluation of an 8-Kilodalton Subunit of Antigen B from Echinococcus multilocularis-images/image4_1.jpeg
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_2.jpeg
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image3_2.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image3_1.jpeg
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image2_2.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_16.jpeg
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_4.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_5.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_18.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_3.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image6_1.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image6_2.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_17.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_6.jpeg
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_14.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_15.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_11.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_10.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_12.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_7.jpeg
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_8.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_9.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image2_1.jpeg
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/images.txt
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_13.png
A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells-images/image4_1.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image1_2.png
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image5_4.png
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image4_2.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image5_6.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image1_1.png
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image5_1.png
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image3_1.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image5_7.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image4_3.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image5_2.png
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image5_3.png
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image4_4.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image3_4.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/images.txt
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image3_5.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image5_8.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image3_2.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image4_1.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image5_5.jpeg
Tumor necrosis factor alpha down-regulates the Na+-K+ ATPase and the Na+-K+2Cl- cotransporter in the kidney cortex and medulla-images/image3_3.jpeg
Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells-images/image8_2.jpeg
Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells-images/image7_1.jpeg
Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells-images/image2_1.jpeg
Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells-images/images.txt
Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells-images/image6_1.jpeg
Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells-images/image4_1.jpeg
Expression and Differentiation between OCT4A and Its Pseudogenes in Human ESCs and Differentiated Adult Somatic Cells-images/image8_1.jpeg
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image3_1.png
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image1_1.jpeg
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image11_1.jpeg
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image13_1.jpeg
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image7_1.png
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image4_1.png
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image9_1.jpeg
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image8_1.png
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/images.txt
The Retromer Complex Is Required for Rhodopsin Recycling and Its Loss Leads to Photoreceptor Degeneration-images/image6_1.jpeg
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image1_2.png
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image4_2.jpeg
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image8_2.jpeg
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image1_1.png
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image7_3.png
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image7_2.png
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image7_1.png
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image5_1.jpeg
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image5_2.jpeg
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/images.txt
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image6_1.jpeg
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image4_1.jpeg
TNF-a down-regulates the NaCeKC ATPase and the Na+-K+-2Cl- cotransporter in the rat colon via PGE2-images/image8_1.jpeg
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image5_1.png
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image3_1.jpeg
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image7_1.png
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image15_1.png
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image6_1.png
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image13_1.png
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image11_1.png
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/images.txt
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image16_1.jpeg
Astakine 2ÃÂthe Dark Knight Linking Melatonin to Circadian Regulation in Crustaceans-images/image9_1.png
Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblast-images/image3_1.jpeg
Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblast-images/image7_1.png
Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblast-images/image6_1.png
Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblast-images/image5_1.jpeg
Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblast-images/image6_2.png
Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblast-images/images.txt
Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblast-images/image4_1.jpeg
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image1_2.png
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image1_1.png
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image5_1.png
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image10_1.png
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image7_1.jpeg
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image6_1.png
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image4_1.png
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image9_1.jpeg
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/images.txt
STAT1 and STAT3 phosphorylation by porins are independent of JAKs but are dependent on MAPK pathway and plays a role in U937 cells production of interleukin-6-images/image8_1.jpeg
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/image4_2.jpeg
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/image1_1.jpeg
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/image3_1.jpeg
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/image7_1.jpeg
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/image5_1.jpeg
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/images.txt
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/image4_1.jpeg
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/image8_1.jpeg
Upregulation of PIAS1 protects against sodium taurocholate-induced severe acute pancreatitis associated with acute lung injury-images/image1_2.jpeg
cDNA cloning and functional analysis of goose interleukin-2 -images/image1_2.png
cDNA cloning and functional analysis of goose interleukin-2 -images/image3_2.png
cDNA cloning and functional analysis of goose interleukin-2 -images/image1_1.png
cDNA cloning and functional analysis of goose interleukin-2 -images/image3_1.jpeg
cDNA cloning and functional analysis of goose interleukin-2 -images/image7_1.jpeg
cDNA cloning and functional analysis of goose interleukin-2 -images/image2_1.jpeg
cDNA cloning and functional analysis of goose interleukin-2 -images/images.txt
cDNA cloning and functional analysis of goose interleukin-2 -images/image6_1.jpeg
cDNA cloning and functional analysis of goose interleukin-2 -images/image4_1.jpeg
The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production-images/image1_1.png
The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production-images/image3_1.jpeg
The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production-images/image6_2.jpeg
The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production-images/image5_1.jpeg
The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production-images/image2_1.jpeg
The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production-images/images.txt
The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production-images/image6_1.jpeg
The Helicobacter pylori Urease B Subunit Binds to CD74 on Gastric Epithelial Cells and Induces NF-__B Activation and Interleukin-8 Production-images/image4_1.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image4_2.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image1_1.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image6_3.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image6_2.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image5_1.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image5_2.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image5_3.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/images.txt
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image6_1.jpeg
Edwardsiella tarda Eta1, an In Vivo-Induced Antigen That Is Involved in Host Infection-images/image4_1.jpeg
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image1_2.png
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image1_1.png
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image3_1.jpeg
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image4_2.png
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image5_1.jpeg
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image5_2.jpeg
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image2_1.jpeg
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/images.txt
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image6_1.jpeg
Interleukin-1 b inhibits NaC-KCATPase activity and protein expression in cardiac myocytes-images/image4_1.jpeg
TGF-b-Smad3 Stimulates Stem Cell-Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation-images/image1_1.jpeg
TGF-b-Smad3 Stimulates Stem Cell-Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation-images/image11_1.jpeg
TGF-b-Smad3 Stimulates Stem Cell-Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation-images/image13_1.jpeg
TGF-b-Smad3 Stimulates Stem Cell-Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation-images/image4_1.png
TGF-b-Smad3 Stimulates Stem Cell-Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation-images/image5_1.jpeg
TGF-b-Smad3 Stimulates Stem Cell-Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation-images/image12_1.jpeg
TGF-b-Smad3 Stimulates Stem Cell-Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation-images/images.txt
TGF-b-Smad3 Stimulates Stem Cell-Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation-images/image9_1.png
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity-images/image5_1.png
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity-images/image7_1.jpeg
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity-images/image9_1.jpeg
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity-images/image9_2.jpeg
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity-images/image8_2.png
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity-images/images.txt
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity-images/image6_1.jpeg
HIV-1 Tat Protein Increases Microglial Outward K+ Current and Resultant Neurotoxic Activity-images/image8_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image1_3.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image3_1.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image1_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image11_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image14_1.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image13_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image10_1.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image12_2.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image7_2.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image5_2.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image15_1.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image7_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image2_1.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image11_2.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image6_1.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image4_1.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image5_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image13_2.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image9_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image8_2.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image12_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/images.txt
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image9_2.png
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image8_1.jpeg
Functional Characterization of Two Structurally Novel Diacylglycerol Acyltransferase2 Isozymes Responsible for the Enhanced Production of Stearate-Rich Storage Lipid in Candida tropicalis SY005-images/image1_2.jpeg
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets-images/image3_1.png
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets-images/image5_1.png
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets-images/image7_1.png
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets-images/image6_1.png
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets-images/image4_1.png
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets-images/image8_1.png
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets-images/images.txt
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets-images/image9_1.png
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image1_3.png
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image1_2.png
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_2.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_10.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image1_1.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image3_1.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_11.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_3.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_4.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image2_2.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_8.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image2_4.png
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_9.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image2_5.png
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image2_3.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image5_1.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_5.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image3_4.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_6.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_7.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image2_1.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/images.txt
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image3_2.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image6_1.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image4_1.jpeg
Drosophila Mgr, a Prefoldin subunit cooperating with von Hippel Lindau to regulate tubulin stability-images/image3_3.jpeg
Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells-images/image3_2.png
Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells-images/image5_1.png
Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells-images/image3_1.jpeg
Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells-images/image5_2.png
Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells-images/image6_1.png
Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells-images/image6_2.png
Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells-images/images.txt
Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells-images/image4_1.jpeg
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate-images/image3_1.jpeg
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate-images/image2_2.jpeg
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate-images/image6_1.png
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate-images/image6_2.png
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate-images/image2_1.jpeg
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate-images/images.txt
Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate-images/image4_1.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image1_3.png
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image1_2.png
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image4_2.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image1_1.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image3_1.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image2_2.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image5_1.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image5_2.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image5_3.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image2_1.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/images.txt
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image3_2.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image6_1.jpeg
The costimulatory immunogen LPS induces the B-Cell clones that infiltrate transplanted human kidneys-images/image4_1.jpeg
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network-images/image10_1.png
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network-images/image7_1.jpeg
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network-images/image11_1.png
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network-images/image5_1.jpeg
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network-images/image8_1.png
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network-images/image12_1.jpeg
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network-images/images.txt
Chronic Morphine Treatment Attenuates Cell Growth of Human BT474 Breast Cancer Cells by Rearrangement of the ErbB Signalling Network-images/image6_1.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_20.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image3_3.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_4.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_3.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image3_1.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_2.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_5.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_19.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_18.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_2.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_5.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_3.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_11.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_1.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_9.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_8.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_10.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_4.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_7.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_8.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_9.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/images.txt
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_6.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_12.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_15.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_14.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image3_2.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image6_1.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_16.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_6.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_17.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_13.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_7.jpeg
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_12.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_10.png
Essential roles of PI(3)KÃÂp110b in cell growth, metabolism and tumorigenesis-images/image2_11.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image3_1.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image1_2.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image1_1.jpeg
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image3_2.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image5_1.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image5_2.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image7_1.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image2_2.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image2_1.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image4_2.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image6_1.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image6_3.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image6_2.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image8_1.png
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/images.txt
Ectopic Expression of a Maize Hybrid Down-Regulated Gene ZmARF25 Decreases Organ Size by Affecting Cellular Proliferation in Arabidopsis-images/image4_1.jpeg
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis-images/image1_1.jpeg
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis-images/image3_1.jpeg
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis-images/image6_1.png
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis-images/image4_1.png
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis-images/image5_1.jpeg
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis-images/image6_2.png
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis-images/images.txt
Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis-images/image1_2.jpeg
Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide-images/image3_1.png
Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide-images/image3_2.png
Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide-images/image3_3.png
Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide-images/image4_4.png
Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide-images/image4_2.png
Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide-images/image4_3.png
Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide-images/image4_1.png
Hemin-Induced Modifications of the Antigenicity and Hemin-Binding Capacity of Porphyromonas gingivalis Lipopolysaccharide-images/images.txt
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/image3_1.png
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/image5_1.png
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/image12_1.png
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/image6_1.png
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/image11_1.png
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/image4_1.png
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/image8_1.png
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/images.txt
Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection-images/image9_1.png
Ovarian cancer cells, not normal cells, are damaged by Mirk-Dyrk1B kinase inhibition-images/image7_1.jpeg
Ovarian cancer cells, not normal cells, are damaged by Mirk-Dyrk1B kinase inhibition-images/image5_1.jpeg
Ovarian cancer cells, not normal cells, are damaged by Mirk-Dyrk1B kinase inhibition-images/image9_1.jpeg
Ovarian cancer cells, not normal cells, are damaged by Mirk-Dyrk1B kinase inhibition-images/image10_1.jpeg
Ovarian cancer cells, not normal cells, are damaged by Mirk-Dyrk1B kinase inhibition-images/images.txt
Ovarian cancer cells, not normal cells, are damaged by Mirk-Dyrk1B kinase inhibition-images/image6_1.jpeg
Ovarian cancer cells, not normal cells, are damaged by Mirk-Dyrk1B kinase inhibition-images/image4_1.jpeg
Effects of Moraxella (Branhamella) ovis Culture Filtrates on Bovine Erythrocytes, Peripheral Mononuclear Cells and Corneal Epithelial Cells-images/image1_1.png
Effects of Moraxella (Branhamella) ovis Culture Filtrates on Bovine Erythrocytes, Peripheral Mononuclear Cells and Corneal Epithelial Cells-images/image3_1.jpeg
Effects of Moraxella (Branhamella) ovis Culture Filtrates on Bovine Erythrocytes, Peripheral Mononuclear Cells and Corneal Epithelial Cells-images/image2_1.jpeg
Effects of Moraxella (Branhamella) ovis Culture Filtrates on Bovine Erythrocytes, Peripheral Mononuclear Cells and Corneal Epithelial Cells-images/images.txt
Effects of Moraxella (Branhamella) ovis Culture Filtrates on Bovine Erythrocytes, Peripheral Mononuclear Cells and Corneal Epithelial Cells-images/image3_2.jpeg
Effects of Moraxella (Branhamella) ovis Culture Filtrates on Bovine Erythrocytes, Peripheral Mononuclear Cells and Corneal Epithelial Cells-images/image4_1.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image1_2.png
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image4_2.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image1_1.png
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image4_3.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image4_4.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image5_1.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image5_2.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image5_3.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/images.txt
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image5_4.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image4_1.jpeg
Effects of ethanol on monosodium urate crystal-induced inflammation-images/image5_5.jpeg
Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__-images/image11_1.jpeg
Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__-images/image7_1.jpeg
Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__-images/image5_1.jpeg
Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__-images/image5_2.jpeg
Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__-images/image10_1.jpeg
Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__-images/images.txt
Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__-images/image6_1.jpeg
Protein Kinase LegK2 Is a Type IV Secretion System Effector Involved in Endoplasmic Reticulum Recruitment and Intracellular Replication of Legionella pneumophila__-images/image8_1.jpeg
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image11_1.jpeg
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image5_1.png
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image13_1.jpeg
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image7_1.png
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image6_1.png
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image9_1.jpeg
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image10_1.jpeg
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/images.txt
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image4_1.jpeg
LPS Unmasking of Shigella flexneri Reveals Preferential Localisation of Tagged Outer Membrane Protease IcsP to Septa and New Poles-images/image8_1.jpeg
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/image1_1.jpeg
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/image6_2.jpeg
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/image7_1.jpeg
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/image5_1.jpeg
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/images.txt
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/image6_1.jpeg
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/image1_3.jpeg
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/image4_1.jpeg
Up-regulation of focal adhesion kinase in non-small cell lung cancer-images/image1_2.jpeg
Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF-images/image1_1.jpeg
Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF-images/image3_1.jpeg
Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF-images/image6_2.jpeg
Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF-images/image7_1.jpeg
Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF-images/image5_1.jpeg
Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF-images/images.txt
Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF-images/image6_1.jpeg
Carbon Ion Radiation Inhibits Glioma and Endothelial Cell Migration Induced by Secreted VEGF-images/image4_1.jpeg
Pharmacokinetics of Naja sumatrana (Equatorial Spitting Cobra) Venom and Its Major Toxins in Experimentally Envenomed Rabbits-images/image1_1.jpeg
Pharmacokinetics of Naja sumatrana (Equatorial Spitting Cobra) Venom and Its Major Toxins in Experimentally Envenomed Rabbits-images/image7_1.jpeg
Pharmacokinetics of Naja sumatrana (Equatorial Spitting Cobra) Venom and Its Major Toxins in Experimentally Envenomed Rabbits-images/image6_1.png
Pharmacokinetics of Naja sumatrana (Equatorial Spitting Cobra) Venom and Its Major Toxins in Experimentally Envenomed Rabbits-images/images.txt
Pharmacokinetics of Naja sumatrana (Equatorial Spitting Cobra) Venom and Its Major Toxins in Experimentally Envenomed Rabbits-images/image4_1.jpeg
The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro-images/image3_1.jpeg
The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro-images/images.txt
The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cells in vitro-images/image4_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image1_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image11_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image7_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image5_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image9_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image10_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/images.txt
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image6_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image4_1.jpeg
Reactive Oxygen Species-Triggered Trophoblast Apoptosis Is Initiated by Endoplasmic Reticulum Stress via Activation of Caspase-12, CHOP and the JNK Pathway in Toxoplasma gondii Infection in Mice-images/image8_1.jpeg
Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background-images/image5_1.png
Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background-images/image7_1.jpeg
Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background-images/image6_1.png
Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background-images/images.txt
Pathological Impact of Hepatitis B Virus Surface Proteins on the Liver Is Associated with the Host Genetic Background-images/image4_1.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image1_3.png
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image1_2.png
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image4_2.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image1_1.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image3_1.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image4_3.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image2_2.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image2_3.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image5_1.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image5_2.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image2_1.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/images.txt
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image3_2.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image6_1.jpeg
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability-images/image4_1.jpeg
Orphan Nuclear Receptor Errc Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH-images/image3_1.png
Orphan Nuclear Receptor Errc Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH-images/image5_1.png
Orphan Nuclear Receptor Errc Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH-images/image2_1.png
Orphan Nuclear Receptor Errc Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH-images/image6_1.png
Orphan Nuclear Receptor Errc Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH-images/image4_1.png
Orphan Nuclear Receptor Errc Induces C-Reactive Protein Gene Expression through Induction of ER-Bound Bzip Transmembrane Transcription Factor CREBH-images/images.txt
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/image3_1.png
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/image4_2.jpeg
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/image4_3.jpeg
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/image5_2.png
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/image6_1.png
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/image5_1.jpeg
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/image6_2.png
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/images.txt
Lymphocyte Function-Associated Antigen 1 Is a Receptor for Pasteurella haemolytica Leukotoxin in Bovine Leukocytes-images/image4_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image1_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image3_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image7_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image5_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image9_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/images.txt
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image6_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image4_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image8_1.jpeg
CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration-images/image1_2.jpeg
Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp. Kurstaki-images/image1_1.jpeg
Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp. Kurstaki-images/image7_1.png
Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp. Kurstaki-images/image4_1.png
Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp. Kurstaki-images/image5_1.jpeg
Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp. Kurstaki-images/images.txt
Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp. Kurstaki-images/image6_1.jpeg
Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp. Kurstaki-images/image8_1.jpeg
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image1_2.png
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image1_1.png
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image5_1.png
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image6_2.jpeg
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image7_1.jpeg
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image4_2.png
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image7_3.jpeg
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/images.txt
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image7_2.jpeg
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image6_1.jpeg
Increased levels of bioactive IL-16 correlate with disease activity during relapsing experimental autoimmune encephalomyelitis (EAE)-images/image4_1.jpeg
Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__-images/image3_1.jpeg
Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__-images/image7_1.jpeg
Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__-images/image5_1.jpeg
Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__-images/image5_2.jpeg
Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__-images/images.txt
Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__-images/image6_1.jpeg
Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__-images/image4_1.jpeg
Nasal Immunization with a Fusion Protein Consisting of the Hemagglutinin A Antigenic Region and the Maltose-Binding Protein Elicits CD11c__ CD8__ Dendritic Cells for Induced Long-Term Protective Immunity__-images/image8_1.jpeg
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image1_2.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image1_1.jpeg
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image3_2.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image3_1.jpeg
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image10_1.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image7_2.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image5_2.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image2_2.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image7_1.jpeg
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image4_2.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image5_1.jpeg
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image6_2.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image8_1.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image2_1.jpeg
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/images.txt
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image6_1.jpeg
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image9_1.png
Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1a Accumulation via Increased Production of Reactive Oxygen Species-images/image4_1.jpeg
X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis-images/image3_1.png
X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis-images/image5_1.png
X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis-images/image7_1.png
X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis-images/image6_1.png
X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis-images/image8_1.png
X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis-images/images.txt
X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis-images/image9_2.png
X-Box Binding Protein 1 (XBP1s) Is a Critical Determinant of Pseudomonas aeruginosa Homoserine Lactone-Mediated Apoptosis-images/image9_1.png
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image3_1.png
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image4_2.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image8_2.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image3_2.png
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image6_2.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image2_2.png
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image7_1.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image2_1.png
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image5_1.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image5_2.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image5_3.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/images.txt
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image7_2.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image6_1.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image5_4.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image4_1.jpeg
Preventive effect of caffeine and curcumin on hepato_ carcinogenesis in diethylnitrosamine_induced rats-images/image8_1.jpeg
Tiam1 is associated with hepatocellular carcinoma metastasis-images/image7_1.jpeg
Tiam1 is associated with hepatocellular carcinoma metastasis-images/image5_1.jpeg
Tiam1 is associated with hepatocellular carcinoma metastasis-images/image9_1.jpeg
Tiam1 is associated with hepatocellular carcinoma metastasis-images/images.txt
Tiam1 is associated with hepatocellular carcinoma metastasis-images/image6_1.jpeg
Tiam1 is associated with hepatocellular carcinoma metastasis-images/image8_1.jpeg
c-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation-images/image11_1.jpeg
c-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation-images/image7_1.jpeg
c-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation-images/image5_1.jpeg
c-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation-images/image9_1.jpeg
c-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation-images/image10_1.jpeg
c-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation-images/images.txt
c-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation-images/image6_1.jpeg
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image3_1.png
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image5_1.png
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image10_1.png
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image12_1.png
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image7_1.png
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image11_1.png
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image4_1.png
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image8_1.png
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/images.txt
Differential Effects of Collagen Prolyl 3-Hydroxylation on Skeletal Tissues-images/image9_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image3_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image1_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image6_2.jpeg
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image10_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image12_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image7_1.jpeg
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image6_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image11_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image4_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image5_1.jpeg
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image9_1.jpeg
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image8_1.png
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/image2_1.jpeg
Cell Atavistic Transition: Paired Box 2 Re-Expression Occurs in Mature Tubular Epithelial Cells during Acute Kidney Injury and Is Regulated by Angiotensin II-images/images.txt
Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections-images/image1_1.jpeg
Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections-images/image3_1.jpeg
Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections-images/image6_2.jpeg
Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections-images/image5_1.jpeg
Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections-images/images.txt
Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections-images/image6_1.jpeg
Augmentation of Epithelial Resistance to Invading Bacteria by Using mRNA Transfections-images/image4_1.jpeg
Bacillus anthracis Capsule Activates Caspase-1 and Induces Interleukin-1__ Release from differentiated THP-1 and Human Monocyte-Derived Dendritic Cells__-images/image1_1.png
Bacillus anthracis Capsule Activates Caspase-1 and Induces Interleukin-1__ Release from differentiated THP-1 and Human Monocyte-Derived Dendritic Cells__-images/image3_1.jpeg
Bacillus anthracis Capsule Activates Caspase-1 and Induces Interleukin-1__ Release from differentiated THP-1 and Human Monocyte-Derived Dendritic Cells__-images/image5_1.jpeg
Bacillus anthracis Capsule Activates Caspase-1 and Induces Interleukin-1__ Release from differentiated THP-1 and Human Monocyte-Derived Dendritic Cells__-images/images.txt
Bacillus anthracis Capsule Activates Caspase-1 and Induces Interleukin-1__ Release from differentiated THP-1 and Human Monocyte-Derived Dendritic Cells__-images/image3_2.jpeg
Bacillus anthracis Capsule Activates Caspase-1 and Induces Interleukin-1__ Release from differentiated THP-1 and Human Monocyte-Derived Dendritic Cells__-images/image4_1.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image1_3.png
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image1_2.png
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image4_2.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image1_1.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image3_1.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image2_2.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image2_3.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image5_1.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image5_2.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image2_1.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/images.txt
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image3_2.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image6_1.jpeg
LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1-images/image4_1.jpeg
Targeting breast cancer-initiating-stem cells with melanoma differentiation-associated gene-7-interleukin-24-images/image7_1.jpeg
Targeting breast cancer-initiating-stem cells with melanoma differentiation-associated gene-7-interleukin-24-images/image5_1.jpeg
Targeting breast cancer-initiating-stem cells with melanoma differentiation-associated gene-7-interleukin-24-images/image9_1.jpeg
Targeting breast cancer-initiating-stem cells with melanoma differentiation-associated gene-7-interleukin-24-images/images.txt
Targeting breast cancer-initiating-stem cells with melanoma differentiation-associated gene-7-interleukin-24-images/image6_1.jpeg
Targeting breast cancer-initiating-stem cells with melanoma differentiation-associated gene-7-interleukin-24-images/image4_1.jpeg
Targeting breast cancer-initiating-stem cells with melanoma differentiation-associated gene-7-interleukin-24-images/image8_1.jpeg
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image1_2.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image1_1.jpeg
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image3_2.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image5_1.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image3_1.jpeg
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image5_2.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image7_1.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image2_2.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image2_3.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image2_1.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image4_2.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image6_2.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image8_1.png
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/images.txt
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image6_1.jpeg
Baicalein Reduces the Invasion of Glioma Cells via Reducing the Activity of p38 Signaling Pathway-images/image4_1.jpeg
Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli-images/image3_1.png
Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli-images/image5_1.png
Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli-images/image10_1.png
Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli-images/image7_1.png
Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli-images/image15_1.png
Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli-images/image6_1.png
Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli-images/images.txt
Multidrug resistance protein MdtM adds to the repertoire of antiporters involved in alkaline pH homeostasis in Escherichia coli-images/image4_1.jpeg
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image1_1.jpeg
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image11_1.jpeg
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image3_1.jpeg
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image10_1.png
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image9_1.jpeg
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image12_1.jpeg
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/images.txt
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image6_1.jpeg
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image4_1.jpeg
S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression-images/image8_1.jpeg
Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide-images/image3_1.png
Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide-images/image4_3.jpeg
Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide-images/image4_2.png
Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide-images/image5_1.jpeg
Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide-images/images.txt
Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide-images/image3_2.jpeg
Role of MyD88 in Diminished Tumor Necrosis Factor Alpha Production by Newborn Mononuclear Cells in Response to Lipopolysaccharide-images/image4_1.jpeg
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image1_1.jpeg
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image3_1.jpeg
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image2_2.png
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image2_1.png
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image4_1.png
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image2_3.jpeg
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image3_4.jpeg
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/images.txt
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image3_2.jpeg
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image1_2.jpeg
IL-13 induces translocation of NF-kappaB in cultured human bronchial smooth muscle cells-images/image3_3.jpeg
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/image1_1.jpeg
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/image11_1.jpeg
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/image7_1.jpeg
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/image9_1.jpeg
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/image10_2.jpeg
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/image10_1.jpeg
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/images.txt
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/image6_1.jpeg
The Type VI Secretion System Encoded in Salmonella Pathogenicity Island 19 Is Required for Salmonella enterica Serotype Gallinarum Survival within Infected Macrophages-images/image8_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image4_2.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image1_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image8_2.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image3_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image6_2.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image8_3.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image8_4.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image7_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image5_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image8_5.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image9_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image5_2.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image8_6.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image9_2.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image5_3.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/images.txt
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image7_2.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image6_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image5_4.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image4_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image8_1.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image1_2.jpeg
Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells-images/image5_5.jpeg
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells-images/image11_1.jpeg
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells-images/image3_1.jpeg
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells-images/image7_1.jpeg
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells-images/image9_1.jpeg
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells-images/image8_1.png
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells-images/image10_1.jpeg
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells-images/images.txt
miR-1915 and miR-1225-5p Regulate the Expression of CD133, PAX2 and TLR2 in Adult Renal Progenitor Cells-images/image4_1.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_3.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_20.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_18.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_1.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_21.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_2.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_23.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_2.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_3.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_22.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_1.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_5.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_7.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_6.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_15.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_4.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_6.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_19.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_4.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_5.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_18.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_24.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_7.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_2.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_12.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_4.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_5.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_13.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_15.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_3.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_1.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_14.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_21.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_11.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_7.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_6.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_10.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_20.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_4.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_11.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_18.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_14.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_2.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_3.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_10.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_19.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_5.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_7.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_12.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_17.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_1.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image5_1.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_13.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_6.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_22.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_17.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image5_2.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_16.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_23.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_8.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_21.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_14.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_18.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_19.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_15.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_20.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_9.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_11.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_24.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_21.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_20.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_25.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_10.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_19.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_12.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_22.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_8.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_9.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/images.txt
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_23.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_16.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_26.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image4_13.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_15.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_8.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_9.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_14.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_17.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_9.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_16.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image1_8.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_13.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image3_17.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_12.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_16.jpeg
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_10.png
Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis-images/image2_11.png
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image1_1.png
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image3_1.jpeg
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image6_2.jpeg
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image7_1.jpeg
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image5_1.jpeg
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image9_1.jpeg
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image9_2.jpeg
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/images.txt
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image6_1.jpeg
The Yersinia pestis Ail Protein Mediates Binding and Yop Delivery to Host Cells Required for Plague Virulence__-images/image8_1.jpeg
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors-images/image7_1.jpeg
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors-images/image5_1.jpeg
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors-images/image9_1.jpeg
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors-images/images.txt
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors-images/image6_1.jpeg
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors-images/image4_1.jpeg
Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors-images/image8_1.jpeg
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image3_1.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image1_2.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image1_1.jpeg
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image3_2.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image3_3.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image5_1.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image3_4.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image2_2.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image2_1.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image4_2.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image4_3.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image6_1.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/image4_1.png
Heat Shock Protein 27 Is Spatially Distributed in the Human Placenta and Decreased during Labor-images/images.txt
Genotyping and Phenotyping of Beta2-Toxigenic Clostridium perfringens Fecal Isolates Associated with Gastrointestinal Diseases in Piglets-images/image4_2.jpeg
Genotyping and Phenotyping of Beta2-Toxigenic Clostridium perfringens Fecal Isolates Associated with Gastrointestinal Diseases in Piglets-images/image5_1.jpeg
Genotyping and Phenotyping of Beta2-Toxigenic Clostridium perfringens Fecal Isolates Associated with Gastrointestinal Diseases in Piglets-images/image5_2.jpeg
Genotyping and Phenotyping of Beta2-Toxigenic Clostridium perfringens Fecal Isolates Associated with Gastrointestinal Diseases in Piglets-images/images.txt
Genotyping and Phenotyping of Beta2-Toxigenic Clostridium perfringens Fecal Isolates Associated with Gastrointestinal Diseases in Piglets-images/image6_1.jpeg
Genotyping and Phenotyping of Beta2-Toxigenic Clostridium perfringens Fecal Isolates Associated with Gastrointestinal Diseases in Piglets-images/image4_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_29.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_10.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_15.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_137.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_12.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_118.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_130.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_12.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_121.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_35.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_199.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_8.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_119.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_14.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_28.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_28.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_16.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_183.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_6.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image10_5.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_78.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_212.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_204.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image18_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_6.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_4.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_32.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_132.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_117.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_24.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_3.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_17.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image7_6.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_25.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image7_3.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_122.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_43.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_33.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_5.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_7.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image18_3.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_7.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image10_4.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_6.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_12.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_10.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_38.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_29.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_9.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_13.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_13.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_134.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_120.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_136.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image7_1.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_39.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_11.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_219.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_185.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_62.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_76.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_89.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image10_3.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_68.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_18.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_147.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_153.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_18.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_184.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image6_6.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image18_4.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_44.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_191.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_13.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_5.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_152.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_146.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_20.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_6.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_22.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_88.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_77.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_63.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_218.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_22.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_75.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_61.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_189.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_131.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_14.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_178.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_150.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_127.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_14.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_193.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_187.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image6_5.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_10.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_48.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image6_4.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_145.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_151.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_179.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_9.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_60.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_74.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_70.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_64.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_58.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_11.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_141.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_169.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_8.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_196.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_182.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_49.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_11.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_126.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_15.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image6_1.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_197.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_15.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_168.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_140.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_188.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_59.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_65.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_71.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_67.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_73.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_220.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_208.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_23.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_110.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_12.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_7.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_142.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_156.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_21.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_181.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image6_3.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_195.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_4.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_8.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_106.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_3.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_45.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_9.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_192.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_19.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_194.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image6_2.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_180.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_19.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_157.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_23.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_143.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_215.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image10_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_209.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_72.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_66.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_20.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_57.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_50.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_20.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_80.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_94.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_144.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_4.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_22.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_166.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_12.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_172.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_7.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_46.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_105.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_4.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_5.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_198.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_13.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_173.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_167.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_129.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_81.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_18.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image10_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_205.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_56.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_42.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_211.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_54.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_207.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_213.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_40.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_97.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_8.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_159.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_171.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_11.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_165.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_109.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_7.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_12.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_31.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_6.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_16.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_125.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_164.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_170.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_16.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_158.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_133.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_82.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_96.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_55.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_69.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_14.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_202.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_51.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_216.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_79.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_92.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_86.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_174.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_160.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_17.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_148.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_17.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_124.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_30.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_3.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_108.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_149.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_161.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_15.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_175.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_9.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_87.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_93.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_217.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_203.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_186.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_52.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_85.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_91.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_19.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_3.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_163.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_177.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_17.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_201.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_190.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_3.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_47.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_104.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/images.txt
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_176.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_16.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_162.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_5.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_21.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_90.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image7_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_84.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_21.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_53.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_200.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_214.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_20.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_34.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_139.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_111.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_8.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_123.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_10.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_10.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_138.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_99.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_135.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_21.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_8.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_37.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_23.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_26.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image7_5.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_2.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_112.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image16_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_154.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_30.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_6.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_4.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_206.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_107.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_113.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_83.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_210.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_95.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_4.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_22.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_36.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_32.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_26.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_5.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image10_6.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_103.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image18_1.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_5.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_102.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_41.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_7.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_31.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_155.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_116.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_3.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image7_4.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_27.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_33.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_27.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_25.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_19.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_9.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_98.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_100.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_114.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image12_11.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_128.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image9_11.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image15_9.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image13_10.jpeg
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_115.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_101.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_18.png
A novel function for p21Cip1 and acetyltransferase p-CAF as critical transcriptional regulators of TGFb-mediated breast cancer cell migration and invasion-images/image19_24.png
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image3_1.png
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_2.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_10.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image8_2.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image3_2.png
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image8_3.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_3.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_4.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image2_2.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_8.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_9.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image2_3.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_5.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_6.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_7.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image2_1.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/images.txt
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image4_1.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image8_1.jpeg
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma-images/image3_3.jpeg
Aucubin, a naturally occurring iridoid glycoside inhibits TNF-_-induced inflammatory responses through suppression of NF-_B activation in 3T3-L1 adipocytes-images/image1_1.jpeg
Aucubin, a naturally occurring iridoid glycoside inhibits TNF-_-induced inflammatory responses through suppression of NF-_B activation in 3T3-L1 adipocytes-images/image3_1.jpeg
Aucubin, a naturally occurring iridoid glycoside inhibits TNF-_-induced inflammatory responses through suppression of NF-_B activation in 3T3-L1 adipocytes-images/image2_1.jpeg
Aucubin, a naturally occurring iridoid glycoside inhibits TNF-_-induced inflammatory responses through suppression of NF-_B activation in 3T3-L1 adipocytes-images/images.txt
Aucubin, a naturally occurring iridoid glycoside inhibits TNF-_-induced inflammatory responses through suppression of NF-_B activation in 3T3-L1 adipocytes-images/image3_2.jpeg
Aucubin, a naturally occurring iridoid glycoside inhibits TNF-_-induced inflammatory responses through suppression of NF-_B activation in 3T3-L1 adipocytes-images/image4_1.jpeg
Aucubin, a naturally occurring iridoid glycoside inhibits TNF-_-induced inflammatory responses through suppression of NF-_B activation in 3T3-L1 adipocytes-images/image1_2.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_9.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_15.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_5.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_23.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image6_3.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_19.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_18.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image3_1.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image6_2.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_4.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_22.png
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_14.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_8.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_3.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image7_1.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_13.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_12.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image6_4.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image5_1.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_24.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_2.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image5_2.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_1.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_11.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_10.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image5_3.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/images.txt
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image7_2.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_17.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image3_2.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image6_1.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image5_4.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_21.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_7.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_6.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_20.jpeg
A Comparative Study for the Evaluation of Two Doses of Ellagic Acid on Hepatic Drug Metabolizing and Antioxidant Enzymes in the Rat-images/image10_16.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image1_3.png
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image1_2.png
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image4_2.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image1_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image8_2.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image3_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image6_2.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image2_2.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image7_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image5_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image9_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image5_2.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image9_2.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image10_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image2_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/images.txt
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image7_2.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image3_2.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image6_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image4_1.jpeg
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility-images/image8_1.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_19.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_10.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_25.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_15.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_31.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_27.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_5.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_21.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_15.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_7.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_29.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_45.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_6.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_20.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_4.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_42.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_30.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_24.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_28.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_18.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_32.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_16.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_26.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_6.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_16.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_6.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image11_1.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_16.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_4.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_6.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_32.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_5.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_3.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_7.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_8.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_24.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_17.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_27.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_23.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_13.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_25.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_3.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_2.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_1.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_13.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_33.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_10.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_7.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_12.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_34.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_2.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_7.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_17.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_22.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_12.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_20.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_29.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_2.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_2.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_21.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_11.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_3.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_30.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_20.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_1.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_39.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_35.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_21.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_62.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_33.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_17.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_34.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_63.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_5.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_48.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_47.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_11.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_49.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_61.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_55.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_21.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_18.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_29.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_14.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_43.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_38.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_9.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_19.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_44.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_60.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_48.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_64.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_40.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_58.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_45.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_8.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_20.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_59.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_65.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_43.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_10.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_4.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_1.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_11.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_57.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_12.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_7.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_36.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_13.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_12.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_42.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_56.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_40.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_54.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_46.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_35.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_41.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_51.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_49.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_14.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_24.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_25.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_50.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_44.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_52.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_46.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_13.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_17.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_3.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_14.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/images.txt
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_6.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_16.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_21.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_53.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_38.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_20.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_10.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_3.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_34.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_47.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_33.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_10.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_23.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_18.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_2.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_11.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_35.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_39.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_24.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_15.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_13.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_23.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_37.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_1.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_23.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_30.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_4.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_22.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_36.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image11_3.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_37.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_14.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_1.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_4.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_12.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_22.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_26.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_16.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_8.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_5.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_15.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_28.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_36.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image11_2.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_32.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_26.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_8.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_5.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_9.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_9.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_22.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_27.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_17.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_31.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_15.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_9.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_19.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_9.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_19.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image6_22.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_11.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_19.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_25.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_31.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_23.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_24.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image5_18.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_41.jpeg
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image7_8.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_28.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image9_18.png
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion and breast cancer cell dissemination in vivo-images/image10_14.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image3_1.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image1_2.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image1_1.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image5_1.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image7_1.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image2_2.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image4_2.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image6_2.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image5_2.jpeg
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image8_1.png
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image2_1.jpeg
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/images.txt
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image3_2.jpeg
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image6_1.jpeg
Epigenetic Regulation of Cardiac Progenitor Cells Marker c-kit by Stromal Cell Derived Factor-1a-images/image4_1.jpeg
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image1_1.jpeg
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image7_3.png
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image7_1.png
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image6_1.png
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image4_1.png
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image8_1.png
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image8_2.png
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/images.txt
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image7_2.jpeg
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image9_1.png
Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn-images/image1_2.jpeg
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image3_2.png
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image3_3.png
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image1_1.png
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image3_1.jpeg
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image3_7.png
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image3_6.png
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image3_5.png
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image7_1.jpeg
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image7_3.jpeg
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image3_4.jpeg
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/images.txt
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image7_2.jpeg
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy-images/image4_1.jpeg
First Infection with VanD-Type Glycopeptide-Resistant Enterococcus faecium in Europe-images/image1_1.png
First Infection with VanD-Type Glycopeptide-Resistant Enterococcus faecium in Europe-images/image2_2.jpeg
First Infection with VanD-Type Glycopeptide-Resistant Enterococcus faecium in Europe-images/image2_1.jpeg
First Infection with VanD-Type Glycopeptide-Resistant Enterococcus faecium in Europe-images/images.txt
Estrogen receptor _ inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2-images/image3_1.png
Estrogen receptor _ inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2-images/image6_2.jpeg
Estrogen receptor _ inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2-images/image5_1.jpeg
Estrogen receptor _ inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2-images/image5_2.jpeg
Estrogen receptor _ inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2-images/images.txt
Estrogen receptor _ inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2-images/image6_1.jpeg
Estrogen receptor _ inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2-images/image4_1.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_9.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_7.png
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_21.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_15.png
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_13.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_15.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_6.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_5.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_9.png
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_23.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_2.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_6.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_11.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_3.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_17.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_19.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_16.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_18.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_2.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_10.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_22.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_3.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_7.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_4.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_14.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_12.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_20.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_8.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_3.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_4.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_26.png
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_11.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_8.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_5.png
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_15.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_4.png
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_9.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_13.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_12.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_14.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_9.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_10.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_18.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_16.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_1.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_24.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_5.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_1.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_2.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_13.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_7.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_2.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_6.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_2.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_1.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_11.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_17.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_25.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_24.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_16.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_8.png
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_10.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_3.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_7.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_3.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_14.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/images.txt
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_6.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_12.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_19.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_17.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_11.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_8.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_10.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_23.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_8.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_15.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_1.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_13.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_4.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_21.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_4.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_7.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_5.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_6.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_1.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_20.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_5.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_12.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_14.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_22.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image9_11.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image5_9.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image8_10.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image6_18.jpeg
Cyclin D1 cooperates with p21 to regulate TGFb-mediated breast cancer cell migration and tumor local invasion-images/image10_16.jpeg
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/image3_1.png
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/image6_3.jpeg
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/image6_2.jpeg
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/image5_2.png
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/image5_3.png
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/image6_1.png
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/image4_1.png
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/image5_1.jpeg
Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines-images/images.txt
Physical characterisation of Tenacibaculum maritimum for vaccine development-images/image1_2.png
Physical characterisation of Tenacibaculum maritimum for vaccine development-images/image4_2.jpeg
Physical characterisation of Tenacibaculum maritimum for vaccine development-images/image1_1.png
Physical characterisation of Tenacibaculum maritimum for vaccine development-images/image5_1.jpeg
Physical characterisation of Tenacibaculum maritimum for vaccine development-images/image5_2.jpeg
Physical characterisation of Tenacibaculum maritimum for vaccine development-images/images.txt
Physical characterisation of Tenacibaculum maritimum for vaccine development-images/image4_1.jpeg
Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway-images/image1_2.png
Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway-images/image1_1.png
Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway-images/image5_1.png
Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway-images/image7_1.png
Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway-images/images.txt
Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway-images/image6_1.jpeg
Upregulation of tumor necrosis factor-alpha expression by trans10-cis12 conjugated linoleic acid enhances phagocytosis of RAW macrophages via a peroxisome proliferator-activated receptor gamma-dependent pathway-images/image4_1.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image4_2.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image1_1.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image3_1.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image7_1.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image5_1.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image5_2.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/images.txt
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image6_1.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image4_1.jpeg
Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells-images/image1_2.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image1_1.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image11_1.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image3_1.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image7_1.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image5_1.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image11_4.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/images.txt
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image6_1.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image11_3.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image1_3.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image8_1.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image11_2.jpeg
Anti-ribosomal-P antibodies accelerate lupus glomerulonephritis and induce lupus nephritis in nai_ve mice-images/image1_2.jpeg
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin-images/image7_1.jpeg
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin-images/image5_1.jpeg
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin-images/image9_1.jpeg
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin-images/image2_1.jpeg
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin-images/images.txt
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin-images/image6_1.jpeg
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin-images/image4_1.jpeg
Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin-images/image8_1.jpeg
Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development-images/image1_1.png
Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development-images/image3_1.jpeg
Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development-images/image5_1.jpeg
Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development-images/images.txt
Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development-images/image4_1.jpeg
Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma-images/image5_1.png
Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma-images/image3_1.jpeg
Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma-images/image7_1.jpeg
Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma-images/image6_1.png
Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma-images/image4_1.png
Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma-images/images.txt
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis-images/image7_1.jpeg
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis-images/image5_1.jpeg
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis-images/image9_1.jpeg
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis-images/images.txt
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis-images/image6_1.jpeg
RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis-images/image8_1.jpeg
Development and Evaluation of a Sensitive and Specific Assay for Diagnosis of Human Toxocariasis by Use of Three Recombinant Antigens (TES-26, TES-30USM and TES-120)-images/image1_1.png
Development and Evaluation of a Sensitive and Specific Assay for Diagnosis of Human Toxocariasis by Use of Three Recombinant Antigens (TES-26, TES-30USM and TES-120)-images/image3_1.jpeg
Development and Evaluation of a Sensitive and Specific Assay for Diagnosis of Human Toxocariasis by Use of Three Recombinant Antigens (TES-26, TES-30USM and TES-120)-images/images.txt
Development and Evaluation of a Sensitive and Specific Assay for Diagnosis of Human Toxocariasis by Use of Three Recombinant Antigens (TES-26, TES-30USM and TES-120)-images/image3_2.jpeg
Development and Evaluation of a Sensitive and Specific Assay for Diagnosis of Human Toxocariasis by Use of Three Recombinant Antigens (TES-26, TES-30USM and TES-120)-images/image4_1.jpeg
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/image3_1.png
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/image1_1.jpeg
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/image5_1.png
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/image7_1.png
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/image6_1.png
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/image4_1.png
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/image6_2.png
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/images.txt
Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity-images/image8_1.jpeg
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image1_2.png
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image8_2.jpeg
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image1_1.png
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image6_2.jpeg
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image8_3.jpeg
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image7_1.jpeg
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image9_1.jpeg
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/images.txt
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image6_1.jpeg
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image4_1.jpeg
Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome-images/image8_1.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_5.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_12.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_20.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image10_7.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image1_2.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_4.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_6.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image10_5.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_6.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image1_1.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_3.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_7.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image3_1.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_3.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_2.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image10_1.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_2.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_7.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image10_4.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_19.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_18.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image10_3.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_13.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_1.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_7.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_24.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_5.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_13.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_11.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_12.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_14.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_9.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_10.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_6.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_2.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_28.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_8.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_14.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_29.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_15.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_15.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_1.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_10.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_17.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_4.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_16.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_1.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image10_2.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_7.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_5.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_26.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image8_1.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_2.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_30.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_18.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_9.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_19.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_25.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_11.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_21.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_8.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_3.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_22.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_4.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_27.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/images.txt
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_6.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_23.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_31.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_12.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_15.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_14.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_10.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_8.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image6_1.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_16.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_20.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_17.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image11_3.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_4.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_5.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image10_6.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_13.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_12.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_9.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_9.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image9_11.jpeg
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_10.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_11.png
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody-images/image12_8.png
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image3_1.png
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image5_6.jpeg
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image5_1.png
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image6_2.jpeg
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image5_7.jpeg
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image7_1.png
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image2_1.png
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image6_1.png
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image4_1.png
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image5_2.jpeg
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image5_3.jpeg
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/images.txt
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image5_8.jpeg
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image5_4.jpeg
Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun-JNK in K562-ADR Cells-images/image5_5.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image1_1.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image6_2.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image7_1.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image5_1.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image9_1.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image5_2.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/images.txt
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image7_2.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image6_1.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image4_1.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image8_1.jpeg
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells-images/image1_2.jpeg
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K-AKT pathway-images/image3_1.png
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K-AKT pathway-images/image5_1.png
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K-AKT pathway-images/image7_1.jpeg
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K-AKT pathway-images/image4_1.png
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K-AKT pathway-images/images.txt
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K-AKT pathway-images/image6_1.jpeg
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K-AKT pathway-images/image9_1.png
Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K-AKT pathway-images/image8_1.jpeg
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image3_1.png
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image1_1.jpeg
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image5_1.png
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image12_1.png
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image7_1.png
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image6_1.png
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image13_1.png
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image11_1.png
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image4_1.png
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/images.txt
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency-images/image9_1.png
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/image4_2.jpeg
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/image5_1.png
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/image5_2.png
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/image7_1.jpeg
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/image2_1.png
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/images.txt
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/image7_2.jpeg
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/image6_1.jpeg
Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus-images/image4_1.jpeg
Distribution of the Secondary Type III Secretion System Locus Found in Enterohemorrhagic Escherichia coli O157:H7 Isolates among Shiga Toxin-Producing E. coli Strains-images/image5_1.jpeg
Distribution of the Secondary Type III Secretion System Locus Found in Enterohemorrhagic Escherichia coli O157:H7 Isolates among Shiga Toxin-Producing E. coli Strains-images/images.txt
Distribution of the Secondary Type III Secretion System Locus Found in Enterohemorrhagic Escherichia coli O157:H7 Isolates among Shiga Toxin-Producing E. coli Strains-images/image6_1.jpeg
Distribution of the Secondary Type III Secretion System Locus Found in Enterohemorrhagic Escherichia coli O157:H7 Isolates among Shiga Toxin-Producing E. coli Strains-images/image4_1.jpeg
Repression of microRNA-768-3p by MEK-ERK signalling contributes to enhanced mRNA translation in human melanoma-images/image3_1.jpeg
Repression of microRNA-768-3p by MEK-ERK signalling contributes to enhanced mRNA translation in human melanoma-images/image7_1.jpeg
Repression of microRNA-768-3p by MEK-ERK signalling contributes to enhanced mRNA translation in human melanoma-images/image5_1.jpeg
Repression of microRNA-768-3p by MEK-ERK signalling contributes to enhanced mRNA translation in human melanoma-images/image10_1.jpeg
Repression of microRNA-768-3p by MEK-ERK signalling contributes to enhanced mRNA translation in human melanoma-images/images.txt
Repression of microRNA-768-3p by MEK-ERK signalling contributes to enhanced mRNA translation in human melanoma-images/image6_1.jpeg
Repression of microRNA-768-3p by MEK-ERK signalling contributes to enhanced mRNA translation in human melanoma-images/image4_1.jpeg
Repression of microRNA-768-3p by MEK-ERK signalling contributes to enhanced mRNA translation in human melanoma-images/image8_1.jpeg
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/image11_1.jpeg
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/image3_1.jpeg
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/image7_1.jpeg
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/image5_1.jpeg
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/image9_1.jpeg
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/image10_1.jpeg
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/images.txt
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/image6_1.jpeg
Mutation of the Diamond-Blackfan Anemia Gene Rps7 in Mouse Results in Morphological and Neuroanatomical Phenotypes-images/image8_1.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_14.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_8.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_18.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image4_2.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_1.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_4.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image3_1.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_5.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_19.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_9.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_15.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_7.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_2.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image7_1.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_12.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_13.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_3.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image5_1.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_6.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image7_3.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image5_2.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_5.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_9.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_10.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_11.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_8.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_4.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_1.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/images.txt
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image7_2.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_16.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image6_1.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_6.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_20.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_3.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image4_1.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_2.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image2_7.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_21.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image7_4.jpeg
Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway-images/image11_17.jpeg
False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-Co-images/image3_1.jpeg
False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-Co-images/image2_1.png
False-Positive Results in a Recombinant Severe Acute Respiratory Syndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid Enzyme-Linked Immunosorbent Assay Due to HCoV-OC43 and HCoV-229E Rectified by Western Blotting with Recombinant SARS-Co-images/images.txt
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels-images/image5_1.png
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels-images/image3_1.jpeg
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels-images/image5_2.png
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels-images/image2_2.png
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels-images/image2_1.png
Spreading Depression Triggers Headache by Activating Neuronal Panx1 Channels-images/images.txt
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image1_3.png
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image1_2.png
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image4_2.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image1_1.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image2_4.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image3_1.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image4_3.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image2_2.png
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image2_3.png
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image5_1.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image5_2.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image2_1.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/images.txt
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image3_2.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image6_1.jpeg
Shox2 is a molecular determinant of depot-specific adipocyte function-images/image4_1.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_6.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image4_2.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_1.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image5_6.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image2_4.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image3_1.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image2_5.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image4_3.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_7.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image4_4.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_7.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image2_2.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image7_1.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image2_3.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image5_1.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_6.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image4_5.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_1.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image7_3.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image5_2.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_5.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_2.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_9.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_10.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_8.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_3.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_4.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image5_3.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image2_1.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/images.txt
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image7_2.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_10.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_8.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image7_5.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image2_6.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image5_4.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_3.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_4.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_5.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image4_1.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image11_2.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image5_5.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image2_7.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image7_4.jpeg
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer-images/image9_9.jpeg
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/image1_1.jpeg
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/image7_1.jpeg
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/image5_1.jpeg
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/images.txt
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/image6_1.jpeg
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/image1_3.jpeg
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/image4_1.jpeg
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/image8_1.jpeg
The effect of transforming growth factor _1 on the crosstalk between autophagy and apoptosis in the annulus fibrosus cells under serum deprivation-images/image1_2.jpeg
DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells-images/image7_1.jpeg
DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells-images/image5_1.jpeg
DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells-images/image9_1.jpeg
DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells-images/images.txt
DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells-images/image6_1.jpeg
DNA Methyltransferase Inhibitors Improve the Effect of Chemotherapeutic Agents in SW48 and HT-29 Colorectal Cancer Cells-images/image4_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image1_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image8_2.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image11_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image7_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image5_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image9_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image5_2.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image10_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/images.txt
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image4_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image8_1.jpeg
Differential activation of the inflammasome in THP-1 cells exposed to chrysotile asbestos and Libby ÃÂÃÂsix-mixÃÂÃÂ amphiboles and subsequent activation of BEAS-2B cells-images/image1_2.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image1_1.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image8_2.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image7_1.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image5_1.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image9_1.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image10_1.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/images.txt
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image6_1.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image4_1.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image8_1.jpeg
The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation-images/image1_2.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_9.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_40.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_15.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_5.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image8_2.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_3.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_43.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_18.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_2.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image8_3.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_4.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_14.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_8.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_3.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_36.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_22.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_41.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_4.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_5.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_5.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_23.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_37.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_11.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_21.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_35.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_7.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_6.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_9.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_20.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_13.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_12.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_24.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_30.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_18.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_8.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_2.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_3.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_19.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_31.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_25.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_10.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_33.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_27.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_4.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image5_1.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_26.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_32.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_2.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_13.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_17.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_7.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image5_2.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_16.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_1.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_11.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_28.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_14.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_34.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_15.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_29.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_11.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_38.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_10.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_10.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image5_3.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_8.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_42.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_9.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/images.txt
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_39.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_6.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_13.png
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_12.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_17.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_1.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image5_4.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_12.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_7.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_6.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image4_1.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image8_1.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image5_5.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image6_14.jpeg
Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells-images/image10_16.jpeg
STAT3 induces muscle stem cell differentiation by interaction with myoD-images/image1_1.jpeg
STAT3 induces muscle stem cell differentiation by interaction with myoD-images/image3_1.jpeg
STAT3 induces muscle stem cell differentiation by interaction with myoD-images/images.txt
STAT3 induces muscle stem cell differentiation by interaction with myoD-images/image3_2.jpeg
STAT3 induces muscle stem cell differentiation by interaction with myoD-images/image4_1.jpeg
STAT3 induces muscle stem cell differentiation by interaction with myoD-images/image1_2.jpeg
STAT3 induces muscle stem cell differentiation by interaction with myoD-images/image3_3.jpeg
.ipynb_checkpoints/images.txt
Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response-images/image11_1.jpeg
Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response-images/image3_1.jpeg
Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response-images/image7_1.jpeg
Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response-images/image5_1.jpeg
Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response-images/image9_1.jpeg
Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response-images/image12_1.jpeg
Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response-images/images.txt
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_21.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_13.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image4_2.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_6.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_11.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_3.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_7.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_17.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_16.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_6.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_1.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_2.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_10.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_7.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_12.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_20.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_10.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image4_4.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_19.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_5.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_6.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_1.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_11.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_31.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_27.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_15.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_9.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_8.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_14.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image4_3.png
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_26.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_30.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_10.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_7.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_4.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_16.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_18.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_1.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image4_5.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_11.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_13.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_3.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_4.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_7.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_15.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_2.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_29.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_21.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_8.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_17.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_25.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_32.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_24.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_16.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_9.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_20.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_28.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_3.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_14.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/images.txt
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_6.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_5.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_2.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_12.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_9.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_19.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_11.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_8.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_23.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_15.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_5.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_2.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_1.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_13.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_4.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image4_1.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_5.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_12.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_3.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_4.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_14.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_22.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image5_9.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image13_10.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image6_18.jpeg
Dual Inhibiting Senescence and Epithelial-to-Mesenchymal Transition by Erythropoietin Preserve Tubular Epithelial Cell Regeneration and Ameliorate Renal Fibrosis in Unilateral Ureteral Obstruction-images/image7_8.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_12.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_6.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_7.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_13.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_18.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image7_1.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_14.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_15.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_19.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_1.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_20.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image7_3.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_2.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_16.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_17.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_3.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/images.txt
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_21.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image7_2.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_10.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_8.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_4.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_5.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_9.jpeg
Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes-images/image9_11.jpeg
Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision-images/image1_2.png
Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision-images/image1_1.png
Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision-images/image5_1.png
Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision-images/image3_1.jpeg
Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision-images/images.txt
Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision-images/image4_1.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_9.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_15.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_5.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image4_2.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_19.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_18.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image4_3.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_4.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_14.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_8.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_3.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image4_4.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image7_1.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_13.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_12.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image5_1.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_2.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image5_2.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_1.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_11.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_10.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image5_3.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/images.txt
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_17.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image6_1.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image5_4.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_21.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_7.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_6.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image4_1.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_20.jpeg
Yangjing Capsule Extract Promotes Proliferation of GC-1 Spg Cells-images/image10_16.jpeg
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes-images/image1_1.jpeg
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes-images/image3_1.jpeg
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes-images/image7_1.jpeg
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes-images/image5_1.jpeg
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes-images/images.txt
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes-images/image6_1.jpeg
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes-images/image4_1.jpeg
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes-images/image1_2.jpeg
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis-images/image11_1.jpeg
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis-images/image5_1.png
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis-images/image13_1.png
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis-images/images.txt
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis-images/image6_1.jpeg
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis-images/image9_1.png
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis-images/image8_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image16_1.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_203.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_217.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_69.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_55.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_41.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_59.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_96.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_82.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_391.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_149.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_175.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_161.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_439.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_377.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_411.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_405.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_363.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_18.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_389.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_404.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_362.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_376.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_410.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_438.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_63.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_160.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_174.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_34.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_148.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_83.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_97.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_40.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_54.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_22.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_68.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_216.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_202.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_228.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_214.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_200.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_55.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_42.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_56.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_81.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_43.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_162.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_176.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_189.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_348.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_360.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_406.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_412.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_374.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_4.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_413.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_375.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_361.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_407.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_349.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_188.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_38.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_177.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_163.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_80.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image14_1.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_57.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_92.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_43.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_201.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_215.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_229.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_211.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_205.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_239.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_47.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_53.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_72.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_84.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image13_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_90.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_167.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_173.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_198.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_39.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_403.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_365.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_371.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_417.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_5.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_15.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_358.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_370.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_416.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_402.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_364.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_199.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_42.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_172.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_166.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_91.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_85.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_54.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_52.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_46.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_238.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_204.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_210.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_206.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_212.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_74.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_345.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_50.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_44.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_78.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_93.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_87.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_170.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_164.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_35.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_158.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_414.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_372.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_366.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_400.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_428.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_62.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_399.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_398.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_19.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_429.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_367.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_401.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_415.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_373.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_159.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_165.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_171.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_58.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_86.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_79.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_45.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_51.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_213.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_207.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_248.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_506.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_260.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_274.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_512.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_53.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_36.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_22.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_45.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_116.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_102.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_328.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_472.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_314.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_300.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_466.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_499.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_4.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_5.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_2.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_498.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_69.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_301.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_467.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_473.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_315.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_329.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_103.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_117.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_6.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_460.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_28.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_23.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_94.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_37.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image17_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_275.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_513.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_507.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_261.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_249.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_511.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_277.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_263.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_505.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_288.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_381.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_14.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_21.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_35.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_129.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_101.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_115.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_49.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_459.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_465.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_303.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_317.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_471.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_7.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_6.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_316.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_470.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_302.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_65.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_458.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_114.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_100.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_128.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_32.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_34.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_20.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_24.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_289.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_262.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_504.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_510.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_276.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_73.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_272.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_514.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_500.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_266.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_528.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_299.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_24.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_30.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_18.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_25.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_104.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_110.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_138.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_33.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_306.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_474.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_312.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_64.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_448.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_2.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_3.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_449.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_475.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_313.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_307.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_461.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_48.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_139.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_111.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_105.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_19.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_31.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_25.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_298.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_529.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_501.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_267.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_273.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_515.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_265.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image11_1.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_503.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_517.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_271.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_259.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_7.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_33.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_95.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_27.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_12.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_7.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_29.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_113.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_107.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_311.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_359.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_477.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_463.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_305.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_339.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_1.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_3.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_488.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_68.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_489.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image15_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_338.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_13.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_462.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_304.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_310.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_476.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_44.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_106.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_112.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_52.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_26.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_32.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_6.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_258.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_516.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_270.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_264.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_502.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_269.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_527.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_241.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_255.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_282.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_296.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_17.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_4.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_137.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_123.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_309.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_453.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_335.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_321.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_447.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_490.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_484.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_485.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_491.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_320.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_446.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_452.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_334.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_10.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_308.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_122.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_136.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_47.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_16.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_51.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_23.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_297.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_283.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image10_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_254.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_526.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_240.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_268.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_71.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_518.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_530.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_256.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_242.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_524.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_8.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_295.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_281.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_194.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_28.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_26.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_8.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_14.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_30.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_108.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_120.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_134.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_478.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_67.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_444.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_322.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_336.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_450.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_487.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_493.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_492.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_486.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_337.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_451.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_445.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_323.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_479.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_135.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_121.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_109.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_15.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_29.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_383.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_280.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_294.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_9.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_243.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_525.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_531.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_257.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_519.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_253.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_521.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_247.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_509.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_290.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_284.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_11.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_39.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_382.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_125.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_131.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_119.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_327.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_441.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_455.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_333.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_469.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_482.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_140.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_496.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_497.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_483.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_468.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_66.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_454.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_332.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_326.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_440.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_31.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_118.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_130.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_124.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_195.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_38.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_27.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_10.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_285.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_291.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_70.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_508.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_520.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_246.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_252.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_244.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_522.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_250.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_278.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_287.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_293.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_12.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_50.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_132.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_126.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_46.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_330.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_456.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_442.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_324.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_11.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_318.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_495.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_481.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_8.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image12_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_9.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image2_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_480.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_494.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_319.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/images.txt
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_443.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_325.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_331.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_457.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_127.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_133.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_5.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_13.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image17_2.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_292.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_286.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_279.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_251.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_245.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_523.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_222.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_236.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_20.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_48.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_74.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_60.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_168.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_36.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_154.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_197.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_183.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_61.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_418.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_356.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_430.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_424.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_342.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_395.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_350.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_380.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_394.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_9.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_425.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_343.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_357.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_431.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_419.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_182.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_196.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_141.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_155.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_169.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_61.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_75.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_49.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_237.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_223.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_209.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_235.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_221.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_63.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_77.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_464.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_88.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_2.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_143.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_157.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_180.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_369.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_341.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_427.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_433.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_355.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_396.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_397.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_432.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_354.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_340.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_426.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_368.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_16.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_181.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_156.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_142.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_41.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_89.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_76.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_62.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_57.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image9_1.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_220.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_234.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_208.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_230.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_224.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_218.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_66.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_72.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_56.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_99.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_388.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_146.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_152.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_40.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_185.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image8_1.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_191.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_422.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_344.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_436.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_378.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_17.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_387.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_393.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_392.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_386.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_379.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_351.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_437.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_423.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_190.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_184.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_153.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_147.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_98.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_3.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_73.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_67.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_219.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_225.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_231.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_227.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_233.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_71.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_65.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_59.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_151.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_145.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_179.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_192.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_186.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_435.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_353.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_347.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_421.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_409.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_390.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_384.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_385.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_60.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_408.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_346.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_420.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_434.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_352.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_187.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_193.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_178.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_37.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_144.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_150.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image3_21.jpeg
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_58.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_64.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_70.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_232.png
D14ÃÂSCFD3-dependent degradation of D53 regulates strigolactone signalling-images/image4_226.png
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/image3_1.jpeg
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/image7_1.jpeg
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/image2_1.png
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/image5_1.jpeg
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/images.txt
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/image6_1.jpeg
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/image9_1.png
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/image4_1.jpeg
DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine-images/image8_1.jpeg
Multiple controls affect arsenite oxidase gene expression in Herminiimonas arsenicoxydans-images/image3_1.png
Multiple controls affect arsenite oxidase gene expression in Herminiimonas arsenicoxydans-images/image3_2.png
Multiple controls affect arsenite oxidase gene expression in Herminiimonas arsenicoxydans-images/image5_2.png
Multiple controls affect arsenite oxidase gene expression in Herminiimonas arsenicoxydans-images/image7_1.png
Multiple controls affect arsenite oxidase gene expression in Herminiimonas arsenicoxydans-images/image5_1.jpeg
Multiple controls affect arsenite oxidase gene expression in Herminiimonas arsenicoxydans-images/image8_1.png
Multiple controls affect arsenite oxidase gene expression in Herminiimonas arsenicoxydans-images/images.txt
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image1_1.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image8_2.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image7_1.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image5_1.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image9_1.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image5_2.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/images.txt
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image7_2.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image6_1.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image1_3.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image8_1.jpeg
In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2-images/image1_2.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image8_2.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image3_1.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image7_1.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image5_1.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image7_3.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/images.txt
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image7_2.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image6_1.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image4_1.jpeg
The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans-images/image8_1.jpeg
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas-images/image1_1.jpeg
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas-images/image3_1.jpeg
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas-images/image7_1.jpeg
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas-images/image5_1.jpeg
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas-images/image9_1.jpeg
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas-images/image2_1.jpeg
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas-images/images.txt
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas-images/image8_1.jpeg
Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation-images/image11_1.png
Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation-images/image5_1.jpeg
Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation-images/image10_1.jpeg
Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation-images/image12_1.jpeg
Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation-images/images.txt
Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation-images/image6_1.jpeg
Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation-images/image9_1.png
Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-_B mediated matrix metalloproteinase-1 gene regulation-images/image8_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_17.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image9_6.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_21.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image4_2.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_2.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image8_2.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image3_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image8_3.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image4_3.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_3.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_20.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image10_4.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_16.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image10_3.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_4.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image4_4.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image8_4.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image7_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_8.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_11.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_10.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_9.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image5_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image8_5.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_5.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image9_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image10_2.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image7_3.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image5_2.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image8_6.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_6.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image9_2.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image10_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_13.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_12.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image9_3.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_7.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image8_7.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image5_3.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image2_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/images.txt
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image7_2.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_15.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_19.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image9_4.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image9_5.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image4_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image8_1.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_18.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image7_4.jpeg
Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo-images/image14_14.jpeg
Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases-images/image4_2.jpeg
Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases-images/image1_1.png
Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases-images/image3_1.jpeg
Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases-images/image6_2.jpeg
Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases-images/image5_1.jpeg
Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases-images/images.txt
Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases-images/image6_1.jpeg
Regulated Expression of the Beta2-Toxin Gene ( cpb2) in Clostridium perfringens Type A Isolates from Horses with Gastrointestinal Diseases-images/image4_1.jpeg
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image1_1.png
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image3_1.jpeg
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image6_2.jpeg
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image7_1.jpeg
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image5_1.jpeg
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image5_2.jpeg
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/images.txt
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image3_2.jpeg
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image6_1.jpeg
Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-__B-Independent Manner__-images/image4_1.jpeg
NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection-images/image1_1.jpeg
NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection-images/image7_1.jpeg
NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection-images/image5_1.jpeg
NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection-images/image9_1.jpeg
NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection-images/images.txt
NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection-images/image6_1.jpeg
NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection-images/image4_1.jpeg
NOD2 Signaling Contributes to Host Defense in the Lungs against Escherichia coli Infection-images/image8_1.jpeg
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/image11_1.jpeg
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/image7_1.jpeg
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/image5_1.jpeg
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/image10_1.jpeg
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/image2_1.jpeg
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/images.txt
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/image6_1.jpeg
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/image4_1.jpeg
MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy-images/image8_1.jpeg
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells-images/image3_1.png
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells-images/image5_1.png
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells-images/image7_1.png
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells-images/image2_1.png
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells-images/image6_1.png
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells-images/image4_1.png
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells-images/image8_1.png
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells-images/images.txt
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image8_2.jpeg
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image6_2.jpeg
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image9_1.jpeg
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image10_2.jpeg
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image9_2.jpeg
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image10_1.jpeg
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image9_3.jpeg
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/images.txt
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image6_1.jpeg
Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid __-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPK-images/image8_1.jpeg
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/image4_2.jpeg
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/image5_1.png
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/image3_1.jpeg
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/image4_3.jpeg
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/image6_2.png
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/image5_2.jpeg
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/images.txt
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/image6_1.jpeg
Infection by Streptococcus pyogenes Induces the Receptor Activator of NF-__B Ligand Expression in Mouse Osteoblastic Cells-images/image4_1.jpeg
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image3_2.png
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image5_1.png
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image3_1.jpeg
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image10_1.png
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image10_2.png
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image12_1.png
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image7_1.png
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image9_1.jpeg
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/images.txt
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image6_1.jpeg
Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis-images/image8_1.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image1_1.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image3_1.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image6_2.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/.DS_Store
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image5_1.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image9_1.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image5_2.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image9_2.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image9_3.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/images.txt
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image6_1.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image9_4.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image4_1.jpeg
Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer-images/image1_2.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_9.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_29.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_14.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_21.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_12.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_13.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_20.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_15.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_6.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_5.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_18.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_16.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_25.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_33.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_2.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_1.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_7.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_17.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_16.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_6.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_2.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_32.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_3.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_24.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_17.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_7.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_4.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_14.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_21.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_12.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_20.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_15.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_28.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_8.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_3.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_10.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_23.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_35.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_4.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_7.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_19.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_5.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_1.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_11.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_12.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_39.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_8.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_15.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_26.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_42.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_9.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_13.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_12.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_8.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_43.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_27.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_14.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_38.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_9.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_13.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_10.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_3.png
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_4.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_18.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_34.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_5.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_6.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_22.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_11.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_1.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_2.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_13.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_3.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_7.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_28.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_6.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_5.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_37.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_21.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_12.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_2.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_1.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_11.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_40.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_24.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_17.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_9.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_10.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_11.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_8.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_16.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_25.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_41.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_10.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_3.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_13.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_20.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_7.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_4.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_36.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/images.txt
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_6.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_2.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_12.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_9.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_19.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_22.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_11.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_10.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_23.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_16.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_18.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_8.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_15.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_5.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_1.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_3.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_31.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_27.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_14.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_4.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_7.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_5.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_6.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_15.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_26.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_1.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_2.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_30.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_4.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_14.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_9.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image11_17.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_19.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_22.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image9_11.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image8_10.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_23.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image6_18.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image10_16.jpeg
Involvement of Nrf2-Mediated Upregulation of Heme Oxygenase-1 in Mollugin-Induced Growth Inhibition and Apoptosis in Human Oral Cancer Cells-images/image7_8.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_13.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image8_2.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image6_3.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_1.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image6_2.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image8_3.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_12.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image8_4.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_19.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image6_5.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_6.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image7_1.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_15.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_14.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_7.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image6_4.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_18.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image5_1.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image9_1.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_4.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image5_2.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_21.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image9_2.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_8.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_17.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_16.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_9.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_20.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image5_3.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/images.txt
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image6_6.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_5.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image7_2.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_11.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_2.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image6_1.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image8_1.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_3.jpeg
Low-Level Laser Stimulation on Adipose-Tissue-Derived Stem Cell Treatments for Focal Cerebral Ischemia in Rats-images/image13_10.jpeg
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image1_1.jpeg
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image14_1.png
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image3_1.jpeg
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image10_1.png
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image12_1.png
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image6_1.png
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image11_1.png
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image4_1.png
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image5_1.jpeg
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image15_1.jpeg
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image8_1.png
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/images.txt
Functional EF-Hands in Neuronal Calcium Sensor GCAP2 Determine Its Phosphorylation State and Subcellular Distribution In Vivo and Are Essential for Photoreceptor Cell Integrity-images/image9_1.png
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis-images/image11_1.jpeg
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis-images/image3_1.jpeg
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis-images/image5_1.jpeg
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis-images/image10_1.jpeg
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis-images/images.txt
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis-images/image6_1.jpeg
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis-images/image4_1.jpeg
Loss of the Par3 Polarity Protein Promotes Breast Tumorigenesis and Metastasis-images/image8_1.jpeg
Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease-images/image7_1.png
Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease-images/image6_1.png
Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease-images/image4_1.png
Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease-images/image5_1.jpeg
Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease-images/image10_1.jpeg
Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease-images/images.txt
Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease-images/image9_1.png
Functional Implication of the Hydrolysis of Platelet Endothelial Cell Adhesion Molecule 1 (CD31) by Gingipains of Porphyromonas gingivalis for the Pathology of Periodontal Disease-images/image8_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_15.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_12.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_45.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_69.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_14.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_28.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_16.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_6.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_7.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_11.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_2.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image11_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_49.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_32.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_65.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_24.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_17.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_25.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image13_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_33.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_48.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_3.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_6.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_10.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_7.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image10_4.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_29.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_68.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_12.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_44.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_13.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_76.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_62.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image10_3.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_17.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_4.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_18.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_4.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image12_2.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_34.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image7_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_22.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_63.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_77.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_61.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_75.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_8.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_8.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_43.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_21.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_38.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_74.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_60.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_64.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_70.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_58.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_20.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_39.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_42.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_9.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_9.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_59.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_73.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_23.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_35.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image12_3.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_5.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_5.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_16.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image10_2.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_72.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_57.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image7_3.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_80.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image13_4.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_36.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_6.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_1.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_6.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_3.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_15.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_81.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_2.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image10_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_54.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_3.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_23.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_41.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_2.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_19.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_82.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_55.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_51.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_79.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_56.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_18.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_40.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_83.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_78.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_50.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_52.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_3.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_2.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_14.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_7.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_7.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image12_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_37.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/images.txt
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_13.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image13_5.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_21.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image7_2.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_53.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_20.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_11.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_47.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_10.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_9.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_8.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_26.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_71.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image13_2.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_67.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_30.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image11_3.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_13.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_5.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_4.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_5.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_12.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_4.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image14_1.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_22.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image11_2.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_31.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_66.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image13_3.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_27.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image7_4.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_9.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_19.png
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_8.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_11.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image9_46.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image8_10.jpeg
__-Actinin TvACTN3 of Trichomonas vaginalis Is an RNA-Binding Protein That Could Participate in Its Posttranscriptional Iron Regulatory Mechanism-images/image21_24.jpeg
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/image4_2.jpeg
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/image3_1.jpeg
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/image6_2.jpeg
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/image7_1.jpeg
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/image5_1.jpeg
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/images.txt
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/image7_2.jpeg
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/image6_1.jpeg
HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa-images/image4_1.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_9.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_15.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_5.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image4_2.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image6_3.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_19.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_18.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image6_2.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image4_3.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_4.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_14.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_8.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_3.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image4_4.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image7_1.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_13.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_12.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image6_4.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image5_1.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image4_5.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_2.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image5_2.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image4_6.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_1.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_11.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_10.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image5_3.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/images.txt
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image7_2.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_17.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image6_1.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image5_4.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_21.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_7.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_6.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image4_1.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_20.jpeg
Magnesium Lithospermate B, an Active Extract of Salvia miltiorrhiza, Mediates sGC-cGMP-PKG Translocation in Experimental Vasospasm-images/image10_16.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image1_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image8_2.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image11_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image12_2.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image7_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image5_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image9_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image9_2.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image10_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image12_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/images.txt
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image6_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image8_1.jpeg
Fur-Regulated Iron Uptake System of Edwardsiella ictaluri and Its Influence on Pathogenesis and Immunogenicity in the Catfish Host-images/image11_2.jpeg
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image3_1.png
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image5_1.png
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image10_1.png
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image15_1.png
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image7_1.jpeg
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image13_1.png
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image4_1.png
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image9_1.jpeg
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image8_1.png
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/image12_1.jpeg
RNA-seq Analysis of Host and Viral Gene Expression Highlights Interaction between Varicella Zoster Virus and Keratinocyte Differentiation-images/images.txt
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image1_2.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image1_1.jpeg
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_2.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_3.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image5_1.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_1.jpeg
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_7.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_6.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_4.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_5.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image7_1.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image2_1.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_10.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image4_1.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image6_2.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image8_1.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/images.txt
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_8.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image3_9.png
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image6_1.jpeg
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells-images/image9_1.png
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image1_1.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image3_1.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image3_6.png
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image4_3.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image4_4.png
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image2_2.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image4_6.png
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image4_2.png
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image6_1.png
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image5_1.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image4_5.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image3_4.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image2_1.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/images.txt
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image3_5.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image3_2.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image4_1.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image1_2.jpeg
Signaling pathway underlying the up-regulatory effect of TNF-a on the Na+-K+ ATPase in HepG2 cells-images/image3_3.jpeg
An Extracellular Subtilase Switch for Immune Priming in Arabidopsis-images/image3_1.png
An Extracellular Subtilase Switch for Immune Priming in Arabidopsis-images/image5_1.png
An Extracellular Subtilase Switch for Immune Priming in Arabidopsis-images/image10_1.png
An Extracellular Subtilase Switch for Immune Priming in Arabidopsis-images/image7_1.png
An Extracellular Subtilase Switch for Immune Priming in Arabidopsis-images/image6_1.png
An Extracellular Subtilase Switch for Immune Priming in Arabidopsis-images/image11_1.png
An Extracellular Subtilase Switch for Immune Priming in Arabidopsis-images/image4_1.png
An Extracellular Subtilase Switch for Immune Priming in Arabidopsis-images/images.txt
Aspirin Delimits Platelet Life Span by Proteasomal Inhibition-images/image1_1.jpeg
Aspirin Delimits Platelet Life Span by Proteasomal Inhibition-images/image7_1.png
Aspirin Delimits Platelet Life Span by Proteasomal Inhibition-images/image6_1.png
Aspirin Delimits Platelet Life Span by Proteasomal Inhibition-images/images.txt
Aspirin Delimits Platelet Life Span by Proteasomal Inhibition-images/image4_1.jpeg
Stac3 Inhibits Myoblast Differentiation into Myotubes-images/image1_1.jpeg
Stac3 Inhibits Myoblast Differentiation into Myotubes-images/image7_1.png
Stac3 Inhibits Myoblast Differentiation into Myotubes-images/image4_1.png
Stac3 Inhibits Myoblast Differentiation into Myotubes-images/image5_1.jpeg
Stac3 Inhibits Myoblast Differentiation into Myotubes-images/images.txt
Stac3 Inhibits Myoblast Differentiation into Myotubes-images/image6_1.jpeg
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image3_1.png
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image5_1.png
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image10_1.png
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image7_2.png
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image2_2.png
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image7_1.jpeg
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image6_1.png
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image5_2.jpeg
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image8_1.png
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image2_1.jpeg
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/images.txt
FOXO4-Knockdown Suppresses Oxidative Stress-Induced Apoptosis of Early Pro-Angiogenic Cells and Augments Their Neovascularization Capacities in Ischemic Limbs-images/image4_1.jpeg
Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells-images/image3_2.png
Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells-images/image3_1.jpeg
Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells-images/image5_1.jpeg
Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells-images/image5_2.jpeg
Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells-images/images.txt
Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells-images/image6_1.jpeg
Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells-images/image4_1.jpeg
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image5_1.png
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image6_2.jpeg
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image7_1.jpeg
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image5_2.jpeg
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image8_1.png
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image5_3.jpeg
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/images.txt
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image7_2.jpeg
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image6_1.jpeg
Mannheimia haemolytica Leukotoxin Activates a Nonreceptor Tyrosine Kinase Signaling Cascade in Bovine Leukocytes, Which Induces Biological Effects-images/image4_1.jpeg
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image1_2.png
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image1_1.png
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image6_2.jpeg
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image7_1.jpeg
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image4_2.png
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image4_1.png
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image5_1.jpeg
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image5_2.jpeg
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image5_3.jpeg
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/images.txt
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image7_2.jpeg
Roles of p38 and ERK MAP kinases in IL-8 expression in TNF-a- and dexamethasone-stimulated human periodontal ligament cells-images/image6_1.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image8_2.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image11_1.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image6_2.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image7_1.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image5_1.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image10_2.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image5_2.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image10_1.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/images.txt
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image6_1.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image8_1.jpeg
Cross-talk of alpha tocopherol-associated protein and JNK controls the oxidative stress-induced apoptosis in prostate cancer cells-images/image11_2.jpeg
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image6_2.jpeg
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image5_2.png
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image7_1.png
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image6_1.png
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image5_1.jpeg
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image8_1.png
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image9_2.jpeg
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image10_1.jpeg
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/images.txt
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral- induced Acute Respiratory Distress Syndrome-images/image9_1.png
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis-images/image11_1.jpeg
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis-images/image7_1.jpeg
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis-images/image5_1.jpeg
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis-images/image10_1.jpeg
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis-images/image12_1.jpeg
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis-images/images.txt
Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis-images/image8_1.jpeg
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/image1_1.jpeg
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/image3_1.jpeg
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/image2_1.png
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/image5_1.jpeg
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/image9_1.jpeg
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/image10_1.jpeg
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/images.txt
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/image6_1.jpeg
Molecular Mechanism of SSR128129E, an Extracellularly Acting, Small-Molecule, Allosteric Inhibitor of FGF Receptor Signaling-images/image8_1.jpeg
Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway-images/image1_1.jpeg
Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway-images/image6_2.jpeg
Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway-images/image7_1.jpeg
Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway-images/image5_1.jpeg
Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway-images/images.txt
Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway-images/image6_1.jpeg
Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway-images/image4_1.jpeg
Pseudomonas aeruginosa Outer Membrane Vesicles Modulate Host Immune Responses by Targeting the Toll-Like Receptor 4 Signaling Pathway-images/image8_1.jpeg
Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells-images/image1_1.jpeg
Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells-images/image7_1.jpeg
Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells-images/image9_1.jpeg
Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells-images/image10_1.jpeg
Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells-images/images.txt
Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells-images/image6_1.jpeg
Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells-images/image4_1.jpeg
Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells-images/image8_1.jpeg
Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts-images/image1_2.png
Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts-images/image1_1.png
Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts-images/image7_1.jpeg
Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts-images/image5_1.jpeg
Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts-images/image5_2.jpeg
Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts-images/images.txt
Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts-images/image7_2.jpeg
Opposing Roles for Two Molecular Forms of Replication Protein A in Rad51-Rad54-Mediated DNA Recombination in Plasmodium falciparum-images/image3_1.jpeg
Opposing Roles for Two Molecular Forms of Replication Protein A in Rad51-Rad54-Mediated DNA Recombination in Plasmodium falciparum-images/image7_1.jpeg
Opposing Roles for Two Molecular Forms of Replication Protein A in Rad51-Rad54-Mediated DNA Recombination in Plasmodium falciparum-images/image5_1.jpeg
Opposing Roles for Two Molecular Forms of Replication Protein A in Rad51-Rad54-Mediated DNA Recombination in Plasmodium falciparum-images/images.txt
Opposing Roles for Two Molecular Forms of Replication Protein A in Rad51-Rad54-Mediated DNA Recombination in Plasmodium falciparum-images/image6_1.jpeg
Opposing Roles for Two Molecular Forms of Replication Protein A in Rad51-Rad54-Mediated DNA Recombination in Plasmodium falciparum-images/image4_1.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_12.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_13.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_8.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image9_6.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image4_2.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_2.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_4.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image6_3.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_7.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_6.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image6_2.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_5.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_3.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image4_3.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_9.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_12.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_13.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_10.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image4_4.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_18.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_4.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_2.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image6_5.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_1.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_14.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_8.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image6_8.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_15.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_9.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image6_4.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_3.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image5_1.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_19.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_5.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image4_5.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_11.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image9_1.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_20.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_3.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image6_7.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_6.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image4_6.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image9_2.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_16.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_17.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image9_3.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_7.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_1.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/images.txt
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image6_6.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_2.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_21.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_9.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_11.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_10.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_5.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image6_1.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_6.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image9_4.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image9_5.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image4_1.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_1.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_7.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_4.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image12_11.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image8_10.jpeg
Ethanol Extracts of Fruiting Bodies of Antrodia cinnamomea Suppress CL1-5 Human Lung Adenocarcinoma Cells Migration by Inhibiting Matrix Metalloproteinase-2-9 through ERK, JNK, p38 and PI3K-Akt Signaling Pathways-images/image7_8.jpeg
